<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-KSB
(MARK ONE)
|X| ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 1999
or
|_| TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from _____ to _____
Commission File Number: 000-26857
THE ROSE GROUP CORPORATION OF NEVADA
(Name of Small Business Issuer in Its Charter)
NEVADA 59-3575972
(State or Other Jurisdiction of (I.R.S. Employer
Incorporation or Organization) Identification No.)
1535 NORTHGATE BOULEVARD, SARASOTA, FLORIDA
(Address of Principal Executive Offices)
34234
(Zip Code)
(941) 359-1795
(Issuer's Telephone Number, Including Area Code)
Securities registered under Section 12(b) of the Exchange Act: NONE.
Securities registered under Section 12(g) of the Exchange Act:
common stock, par value $.001 per share
Check if there is no disclosure of delinquent filers in response to Item 405 of
Regulation S-B contained in this form, and no disclosure will be contained, to
the best of registrant's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-KSB or any
amendments to this Form 10-KSB. |X|
<PAGE>
The issuer's revenues for its most recent fiscal year were $389,110.
The aggregate market value of the voting and non-voting common equity held by
non-affiliates computed by reference to the price at which the stock was sold
was approximately $7,095,346.50 as of March 22, 2000. This value is based upon
the price of our shares of common stock sold in our most recent private offering
of $1.50 per share.
The number of shares of common stock outstanding as of March 22, 2000 was
8,342,231.
Transitional Small Business Disclosure Format (check one): Yes |_| No |X|
ii
<PAGE>
TABLE OF CONTENTS
<TABLE>
<CAPTION>
PAGE
PART I
<S> <C> <C>
Item 1. Description of Business............................................................................ 1
Item 2. Description of Property............................................................................ 10
Item 3. Legal Proceedings.................................................................................. 10
Item 4. Submission of Matters to a Vote of Security Holders................................................ 10
PART II
Item 5. Market for the Company's Common Equity and Related Stockholder Matters............................. 11
Item 6. Management's Discussion and Analysis or Plan of Operation.......................................... 15
Item 7. Financial Statements............................................................................... 18
Item 8. Changes in and Disagreements with Accountants on Accounting
and Financial Disclosure........................................................................... 18
PART III
Item 9. Directors, Executive Officers, Promoters and Control Persons;
Compliance with Section 16(a) of the Exchange Act.................................................. 18
Item 10. Executive Compensation............................................................................. 20
Item 11. Security Ownership of Certain Beneficial Owners and Management..................................... 23
Item 12. Certain Relationships and Related Transactions..................................................... 24
Item 13. Exhibits and Reports on Form 8-K................................................................... 24
FINANCIAL STATEMENTS
Report of Independent Certified Public Accountant............................................................. F-1
Consolidated Financial Statements:
Consolidated Balance Sheet at December 31, 1999............................................................... F-2
Consolidated Statements of Operations for the Years Ended December 31, 1999, 1998
and the period March 13, 1997 (date of inception) through December 31, 1997 .............................. F-3
Consolidated Statements of Cash Flows for the Years Ended December 31, 1999, 1998
and the period March 13, 1997 (date of inception) through December 31, 1997............................... F-4
Consolidated Statements of Changes in Stockholders' Deficit for the period March 13, 1997
(date of inception) to December 31, 1999.................................................................. F-6
Notes to Consolidated Financial Statements.................................................................... F-8
</TABLE>
iii
<PAGE>
PART I
ITEM 1. DESCRIPTION OF BUSINESS
OVERVIEW AND RECENT DEVELOPMENTS
Our Company was originally organized as a Nevada corporation under the
name Vascular International of Nevada, Inc. ("Vascular") on February 13, 1996.
As Vascular, we operated as a development stage company that owned medical
technology Vascular needed to make synthetic vascular implants and developed and
marketed such medical technology together with related products and software. We
had very limited operations and earned little revenue. On December 15, 1997,
Vascular acquired The Rose Group Corporation ("Rose Group Delaware"), a
privately held Delaware subchapter S corporation which manufactured and sold
prenatal and postpartum products. After the acquisition, we abandoned our
efforts to further develop and market its medical technology and changed our
name to "The Rose Group Corporation of Nevada" and our principal business,
management and operations to become the operations of Rose Group Delaware. On
March 13, 1997, we became the holding company for the wholly-owned operating
subsidiary, Rose Group Delaware. In February 1998, we terminated the subchapter
S corporation status of Rose Group Delaware. On April 29, 1999, we incorporated
another wholly-owned subsidiary, Rosebaby.com of Utah, Inc. ("Rosebaby") in
order to facilitate the expansion of our "clicks-n-virtual mortar" business to
customer ("B-to-C") E-Commerce and business to business ("B-to-B") Specialty and
Mass Merchant business.
Our current operations are devoted to establishing a new business.
Since our inception, we have required, rather than earned, cash and we have
incurred operating losses. We can give no assurance that the losses will not
continue or that the Company will become profitable in the future.
We have authorized for issuance 50,000,000 shares of common stock, par
value $.001 per share, and 2,000,000 shares of Class A preferred stock, par
value $.001 per share. 7,845,670 shares of our common stock were issued and
outstanding on December 31, 1999 and 8,342,231 on March 22, 2000. No shares of
our preferred stock are currently issued and outstanding.
We are organized into three main divisions which blend both online and
offline hybrid (virtual) business models to work together to bring our products
and services to our market. Those divisions are the B-to-C E-Commerce, B-to-B
Specialty and Mass Merchant and Corporate Divisions.
B-TO-C E-COMMERCE DIVISION:
Our B-to-C E-Commerce Division runs our website, rosebaby.com, which
became operational on October 1, 1999. We received a total of approximately
900,166 requests, 93,284 visitors and 4,045 repeat visitors on our website from
the beginning of its operation through March 21, 2000. However, to date, we have
had minimal revenue from sales of our products and services on our website. We
expect that the number of visitors on the website and the revenues resulting
from sales through the website will increase substantially once we advertise to
attendees of Lamaze classes and the Yahoo Advertising and Promotion campaign to
be initiated in March, 2000. We hired Sun Remarketing, Inc. ("Sun Remarketing")
of Smithfield, Utah to design, construct and operate our website. Sun
Remarketing is a designer of e-commerce websites that process and fulfill orders
through the Internet. Our subsidiary, Rosebaby, currently employs fifteen people
who will provide customer service, warehouse fulfillment and other related
services for our sales through our website.
1
<PAGE>
In order to operate the B-to-C E-Commerce Division, our servers and
other hardware and software necessary to operate our website are located at Sun
Remarketing's facility in Utah and our website is currently operated by Sun
Remarketing from this location. We are in the process of installing a complete
e-commerce system of servers, hardware and software at our facilities in
Sarasota, Florida which will enable us to operate our website from that
location. The Company expects that the installation of this system will be
completed on or before August 1, 2000. We will be able to use a duplicate backup
system to continue the operation of the website if any technical or other
difficulties are encountered with the primary system also located in Sarasota
and it will provide flexibility to assume operational control of the website
from Sun Remarketing if we decide that we need control.
We recently executed an advertising and promotion agreement with Yahoo!
Inc. ("Yahoo") on February 15, 2000 to become an anchor advertiser in the
Babycare shopping area of the website. The agreement is on a limited exclusive
basis, and Yahoo may only promote one other merchant of mother and baby products
on the same area advertising pregnancy products as our advertisements during the
term of the agreement. The agreement also allows us to display our banners on
Yahoo's web pages related to Mother, Baby and Pregnancy products and services,
to link our rosebaby.com website to Yahoo's portal and to e-mail messages to our
targeted consumer base who are select Yahoo customers (the "Yahoo Agreement").
Additionally, through Yahoo's broadcasting network, we will have five television
and one radio station broadcast of prenatal and postpartum educational content
topics, as well as eighteen national chat sessions which will be hosted by
rosebaby.com healthcare and selfcare professionals.
We will have to pay an aggregate amount of $1,000,000 to Yahoo over the
twelve month term of the agreement for Yahoo's promotional services. The payment
terms consist of an initial payment of $250,000 due upon the effective date of
the Yahoo Agreement, and five (5) subsequent payments of $187,500 due on or
before February 22, 2000, May 1, 2000, August 1, 2000 and November 1, 2000. We
have paid to Yahoo in full both the initial payment and the payment due in
February. We have additionally granted Yahoo a warrant to purchase up to 131,185
shares of common stock at an exercise price of $.50 per share. Yahoo will be
able to exercise 87,457 shares of common stock on the date of issuance (February
15, 2000) and will be able to exercise such shares on the earlier of February
15, 2004 or the effective termination date of the Yahoo Agreement. Yahoo will be
able to exercise the remaining portion of the shares underlying the warrant
until the earlier of February 15, 2001 or the effective termination date of the
Yahoo Agreement.
We additionally executed a Remote Merchant Integration Program
Agreement ("Merchant Agreement") that is for a term of twelve months, and on a
month-to-month basis after expiration of the term. Under the Merchant Agreement,
in exchange for Yahoo displaying our product information and pages from our
website on its Yahoo! Shopping website, we are required to pay a percentage of
the revenue that we receive from sales to customers that purchased the products
through the Yahoo! Shopping website within fifteen days from the end of each
quarter during the term of the Merchant Agreement. We expect that the Yahoo
Agreement and the additional Merchant Agreement will increase our B-to-C
E-Commerce Division's business.
B-TO-B SPECIALTY AND MASS MERCHANT DIVISION:
Presently, the B-to-B Specialty and Mass Merchant Division designs,
develops, markets and distributes nursing breast pads, nursing breast pad
holders, nursing foot rests, nursing breast pillows, breast milk refrigeration
bags, manual breast pumps, nursing breast shells, nursing privacy shawls,
maternity compression hose and maternity and nursing apparel. We market these
products through our sales representatives to retail outlets and various food
and drug chains and specialty stores, located primarily in the United States. We
distribute or ship these products to the specialty store and mass merchant
customers from our main facility in Sarasota, Florida. We are in development of
a B-to-B website to give access to customers at specialty stores to
2
<PAGE>
our products through our website on a computer located in the specialty store,
and in essence, creating a virtual store for these customers without requiring
the specialty store to stock or maintain our inventory.
The B-to-B Specialty and Mass Merchant Division is our only division
currently generating significant revenues.
CORPORATE DIVISION:
We intend to begin operating the Corporate Division during this year.
We will offer "turnkey" consulting services to Fortune 1000 companies and
government facilities to help such organizations establish acceptable,
attractive and clean on-site nursing facilities to accommodate nursing mothers
while employed with those organizations. The services we expect to offer through
the Corporate Division include a national lactation consultant hotline for
employees of subscribing companies and monthly support services for the
corporate human resources department. We hired Dr. Francine H. Nichols as an
expert consultant to develop and establish the lactation consulting services.
PRODUCTS AND SERVICES
PRODUCTS:
We are a healthcare/selfcare manufacturer/wholesaler, mass market
seller to retail outlets and direct seller to consumers through e-commerce of
prenatal/maternity products, postpartum/mother and baby products and also
provide related lactation consulting services. We market various types of breast
pads, breast shells, pad holders, nursing shawls, nursing pillows, foot rests,
breast pumps, lumbar supports, maternity support hose, support garments and
other related products under the brand name "The Natural Choice", with the
exception of the maternity support hose, nursing shawls and maternity apparel
which are marketed under the brand name "Lamaze". We use the brand name "Lamaze"
from Lamaze from AMI, Inc. ("LAMI"), which is a for-profit affiliate of the
Lamaze Organization, for certain authorized products. We acquired "The Natural
Choice" from a previous competitor in 1997, but it is not a registered
trademark.
We contract for the manufacture of our prenatal and postpartum products
with a group of independent manufacturing suppliers. We have ongoing
relationships with several domestic and foreign manufacturers for our products.
Our principal manufacturers are Mid-Town Sewing of Middletown, New York and T&T,
Inc. (Thanh Nguyen) of Sarasota, Florida. We have not entered into any formal
contractual relationship with these manufacturers. Instead, we ship the
necessary raw materials for manufacture and negotiate the price of manufacture
on a per piece basis with the manufacturers. We do currently manufacture the
breast pads that we market and distribute through our B-to-B Specialty and Mass
Merchant Division and could purchase the equipment necessary to manufacture
certain other products that we offered.
Sometimes the manufacturers distribute our finished products to the
mass merchant customers, but generally we package and distribute the products
from our main facility. We process and fulfill orders from our B-to-C E-Commerce
Division directly from our main facility in Florida. We cannot guarantee,
however, that we will be successful in maintaining adequate distribution
facilities or that if we are, that we will be able to successfully implement the
mass distribution process necessary to sell to our e-commerce customers. We
anticipate, however, that we can temporarily outsource distribution requirements
to meet any foreseeable product demand.
3
<PAGE>
SERVICES:
We expect that the Corporate Division will offer "turnkey" consulting
services to Fortune 1000 companies and government facilities to help such
organizations establish acceptable, attractive and clean on-site nursing
facilities to accommodate nursing mothers while employed with those
organizations, including a national lactation consultant hotline for employees
of subscribing companies and monthly support services for the corporate human
resources department. Dr. Nichols and Sheldon Rose, our Chief Executive Officer,
President and Chairman of the Board, will be responsible for staffing this
Division and marketing and selling the consulting services. This Division has
not yet commercially operated, but we anticipate rendering services and
receiving revenue from these operations during 2000. We believe that Dr.
Nichols' status as an expert in maternal and child healthcare and her notoriety
and reputation in the childcare industry will give the Corporate Division the
necessary credibility to successfully market its services to Fortune 1000
companies.
We also anticipate the expansion of our 1,000 Points of Light
Associates Program which will source professional services and advice through
our website to our customers and will also enable the distribution of our
brochures and information to expectant and nursing mothers. The 1,000 Points of
Light Associates Program consists of healthcare and selfcare professionals that
we have received credentials from and who have agreed to offer professional
services and advice to our customers. In March, 2000, we successfully obtained
1,000 associates to complete the initial phase of the program, and we hope to
expand into 10,000 Points of Light in the future.
There is pending federal legislation which may be a significant
incentive for companies to utilize our consulting services and products.
Particularly, The Breastfeeding Promotion and Employers' Tax Incentive Act of
1999 (H.R. 1163) was introduced to Congress during the 1999 legislative session.
This bill encourages employers to set up a safe, private and sanitary
environment for women to express or pump breast milk by providing a tax credit
of fifty percent (50%) for employers who set up a lactation location, purchase
or rent lactation related equipment, hire a lactation consultant or otherwise
promote a lactation friendly environment. This bill was referred to the House
Ways and Means Committee on May 17, 1999 and was reintroduced during the
1999-2000 Congressional Session and referred again to the House Ways and Means
Committee where it is still currently pending. We do not know if that such
legislation will be enacted by Congress.
Additionally, H.R. 3861 was introduced in the House of Representatives
on March 8, 2000. This bill proposes to amend the Pregnancy Discrimination Act
of 1978 to Title VII of the Civil Rights Act of 1964 to include lactation
(defined as a condition that may result in the feeding of a child directly from
the breast or the expressing of milk from the breast) as a medical condition,
and would protect the right of mothers to breastfeed and express breast milk in
the workplace.
In September, 1999, Congress enacted into law H.R. 1478, which ensures
a woman's right to breastfeed her child anywhere on federal property where she
and her child are authorized to be.
MARKETING AND SALES
Sales of products through our B-to-B Specialty and Mass Merchant
Division currently account for most of our revenues. We market our products
through our sales representatives to retail outlets such as Target Stores,
Babies-R-Us, Eckerd Drug, and others, as well as to various food and drug chains
and specialty stores, located primarily in the United States. Our products are
generally distributed or shipped to the mass merchant customers from our main
facility in Sarasota, Florida. We have not entered into any marketing,
distribution or supply agreements with any third parties to distribute our
products.
4
<PAGE>
We are expanding our specialty and mass merchant sales force and offer
additional products, such as infant layette products, prams, strollers, high
chairs, bassinets, cradles and maternity apparel. We will be the exclusive
distributors of these products.
We recently executed a new agreement with LAMI to market and distribute
additional products bearing the Lamaze brand name. On March 15, 2000, we entered
into a new sales agreement ending December 31, 2001 (the "Lamaze Agreement")
with LAMI, a for-profit affiliate of the Lamaze Organization, the number one
childbirth and infant care educator in the United States, to exclusively
manufacture, supply, advertise, offer for sale, promote and sell Lamaze brand
name maternity support hose, nursing shawl and maternity and nursing apparel
within the United States of America, its territories and possessions. LAMI will
not grant any sales rights to any third party for the manufacture or sale of the
maternity hose, nursing shawl or maternity and nursing apparel, but LAMI retains
the right to sell any of the Lamaze products through its own network with our
consent. Lamaze International or LAMI are not prohibited from marketing and
selling, or entering into agreements with third parties, including our
competitors, to market and sell, other prenatal and postpartum products under
the brand name "Lamaze" which could be sold in our market. We do not believe
that Lamaze International or LAMI have entered into any such agreements with
third-party competitors, but we cannot verify that they have not.
In consideration for such manufacturing, sales and distribution rights,
the Lamaze Agreement requires us to pay to LAMI a fee equal to five percent (5%)
of the net sales of the maternity support hose, nursing shawl and maternity and
nursing apparel. We paid $25,000 to LAMI on March 9, 2000 under the terms of the
Lamaze Agreement and we are required to pay a minimum payment against sales in
the sum of $25,000 on February 15th and August 15th of each year. All of the
above payments are non-refundable advances on the fee due to LAMI upon same year
net sales of Lamaze Products and are credited against the fees payable on such
sales. This Lamaze Agreement supersedes the terms of the previous agreement
between the parties, which required us to pay LAMI a fee equal to nine percent
(9%) of the net sales with a minimum fee of $45,000 and to meet a required
minimum net sales of $500,000 for the fiscal year. We paid all of the required
fees under the previous agreement during 1999.
In addition, we plan to develop and market a "rosebaby.com" brand line
of products for sale in upscale department and specialty stores. We anticipate
that the "rosebaby.com" brand line may include diaper cover sheets, pull-up
shirts, snap-side shirts, receiving blankets, training pants, bibs, wash cloths
and hooded towels, and that we will distribute those products though our
website.
We intend to spend a substantial portion of our resources on developing
and significantly increasing the sales of our products and services on our
website to our targeted consumer base. We expect that the Yahoo Agreement will
be essential to this area of development. We expect that the website will be our
primary source of revenue for the years 2000 and 2001.
We have also agreed with LAMI that (i) Lamaze International will
distribute our rosebaby.com/Lamaze product brochure to participants in Lamaze
classroom training, and (ii) we can distribute Lamaze products through the
rosebaby.com Internet website, our B-to-B Specialty and Mass Merchant Division
and our Corporate Division. We hope that through our brochure distribution to
expectant mothers, we can achieve a five percent penetration of the potential
annual market of 2,500,000 expectant and breastfeeding mothers who attend Lamaze
class and use the Internet and/or call our toll free order number
(1-87-rosebaby) during our first full year of website operations. Although we
believe that a five percent market penetration of Lamaze class attendees is
reasonable based upon our internal market research and our management's prior
experience, we cannot be sure that we will reach such level of market
penetration.
5
<PAGE>
Given the nature of e-commerce business, we do not expect any single
customer to account for a significant percentage of our B-to-C E-Commerce
business, or any one or a few customers of our Corporate Division to account for
a substantial portion of that division's revenues. Our B-to-B Specialty and Mass
Merchant Division has historically relied on sales to major retailers in the
United States, such as Target Stores, Babies-R-Us and Eckerd, for a substantial
portion of its revenue. In 1997, sales to significant customers comprised 67% of
the total sales of our B-to-B Specialty and Mass Merchant Division, in 1998,
sales to significant customers comprised 39%, and in 1999, sales to significant
customers comprised 90%, of the total sales of our B-to-B Specialty and Mass
Merchant Division. We do not have any written contractual arrangements to sell
and/or supply our products to any major retailer, and, although no negotiations
have taken place to date, we would like to make such definitive agreements with
one or more large retailers. We cannot assure you, however, that we will be able
to enter into any such agreements.
INTELLECTUAL PROPERTY
We secured the registration of the domain name "ROSEBABY.COM" on April
23, 1999. We also hold domain name registrations for the domain names
"ROSEKID.COM", "ROSEOUTLET.COM" and "ROSEBABYMART.COM" which we may use in our
future operations. We have applied to the United States Patent and Trademark
Office for the trademarks to "ROSEBABY.COM" on June 16, 1999, "ROSEBABY" on July
7, 1999, the "rosebaby" logo consisting of a baby nestled within a single red
rose on July 7, 1999, and to use "ROSEBABY.COM" with the "rosebaby" logo
together on July 7, 1999, and the applications are still pending approval and
the trademarks have not been secured to date.
Under the terms of the Lamaze Agreement, we have the exclusive right to
manufacture, package, supply, advertise, offer for sale, promote and sell
certain Lamaze brand name products which include maternity hose, a nursing shawl
and maternity and nursing apparel. We may place the "Lamaze" mark along with the
(R) (registered trademark symbol) on the products and any advertising, packaging
and marketing materials for these products.
We also entered into a Licensing Agreement with Valda K. Hemming, d/b/a
Pretty/Private, dated January 9, 1998. We are granted a license under this
agreement to manufacture, arrange for the manufacture and sell a patented
product known as the "Privacy Shawl", Patent No. 5,008960. Pursuant to such
agreement, we pay Pretty/Private a royalty fee equal to 7.5% of the net selling
price of each shawl.
BUSINESS STRATEGY
We plan to continue to develop the business of being a
healthcare/selfcare manufacturer/wholesaler, B-to-B mass market seller to retail
outlets and direct seller to consumers through the Internet of prenatal and
postpartum products and related consulting services. We hope to market other
brands of prenatal and postpartum products as well as products for babies
through Internet sales.
We hope to establish marketing strength primarily through our
relationship with LAMI and our use of the "Lamaze" brand name on our maternity
support hose, nursing shawl and maternity and nursing apparel products. The
Lamaze brand name is immediately recognized and accepted by the consumer. We
anticipate reaching a projected 2,500,000 expectant mothers, as well as family
members who attend Lamaze classes each year because of our agreement with LAMI.
Approximately 150,000 Lamaze classes are taught each year, and we will target
the expectant mothers and fathers who attend such classes and invite them to
visit our website, www.rosebaby.com, and review the various products that will
be offered on it. We hope that our 1,000 Points of Light Associates Program will
further the distribution of our rosebaby.com/Lamaze products brochure through
6
<PAGE>
childbirth educators, nurses, lactation consultants, pediatricians,
obstetricians, infant massage therapists and other healthcare/selfcare
professionals, a brochure which we have developed and was approved by LAMI and
Lamaze International. The distribution of this brochure will enable the targeted
consumer market to easily locate our prenatal and postpartum products.
We have distributed copies of our rosebaby.com/Lamaze products brochure
to 11,000 certified childbirth educators in the United States, 5,000 lactation
consultants, 12,000 maternity nurses in hospitals throughout the country and we
anticipate distributing to other healthcare professionals who work with and
educate new and expectant mothers. In total, we intend to distribute sufficient
copies of our brochure on a regular scheduled monthly or quarterly basis to each
of the healthcare professionals previously mentioned. We also intend to be an
advertiser in LAMAZE PARENTS MAGAZINE and LAMAZE BABY MAGAZINE which will be
handed out and/or mailed to all Lamaze classroom attendees. We do not believe
that Lamaze International's recently announced sale of Lamaze Publishing, which
publishes magazines and videos under the Lamaze label, will adversely affect our
goal to be an advertiser in the various Lamaze magazines since we will attempt
to find a new publisher to increase recognition of the rosebaby.com website as a
source of high quality, specialty maternity/new baby products.
In April 1999, we entered into an oral arrangement with Sun Remarketing
to assist us with the design, development, construction and initiation of
operation of our website and Sun Marketing agreed to render certain computer
engineering and other operational support services in connection with the
continuing operation of the website. We entered into a written agreement with
Sun Remarketing on October 15, 1999 (the "Sun Remarketing Agreement"). Under the
Sun Remarketing Agreement, Sun Remarketing is responsible for providing all of
the hardware, software and related design and computer engineering services
necessary to create and operate our website. Sun Remarketing also must register
our website with search engines such as Yahoo, Lycos and Excite, obtain credit
card processing approvals for the website and render other related operational
support and consulting services, including giving advice about banner
advertising and other new advertising concepts for the Internet.
We issued 50,000 shares of common stock to Sun Remarketing for its
initial design and construction of our website and an option to an officer of
Sun Remarketing to purchase an additional 50,000 shares at $.50, and the officer
exercised the option and paid for the shares on October 15, 1999. Sun
Remarketing, or its principal officer, has the right to purchase an additional
50,000 shares of common stock at a price of $.50 per share at any time before
December 31, 2000. We also must pay Sun Remarketing a minimum monthly fee of
$5,000 a month for its computer engineering services, and if the value of the
computer engineering services rendered or performed is greater than $5,000 per
month, we must pay Sun Remarketing for the excess work at the rate of $50 per
hour for executive computer specialists. At December 31, 1999, we owed Sun
Remarketing $31,832 in connection with the agreement reached in October. We
anticipate, however, reaching an agreement with Sun Remarketing to issue common
stock in payment of the amount currently owed to them.
The Sun Remarketing Agreement does not have a definitive termination
date. However, either party may cancel the Agreement at any time after December
31, 1999 upon sixty (60) days written notice to the other party.
We anticipate expanding our exposure on the Internet during the next
twelve months through our website. We designed our rosebaby.com website to
attract not only new and expectant mothers, but also fathers, grandparents,
aunts, uncles and other friends and family members of the new mother and new
baby who may also have a need or desire to purchase specialty maternity and new
baby products during the first four to five years of its life. We believe that
the Internet will become the major resource for our future growth and expansion.
7
<PAGE>
Accordingly, our current focus is on developing a sophisticated website
for the maternity/new baby market. We will incorporate an on-line ordering
service and offer a secured website to increase our on-line e-commerce. To
facilitate the on-line ordering process, we have, through our wholly-owned
subsidiary, Rosebaby, applied for and established accounts with the following
credit facilities: American Express, Discover, Visa and MasterCard. We also
intend to further develop other marketing concepts such as discount coupons,
promotional telephone cards and the expansion of our 1,000 Points of Light
Associates Program which will source professional services through our website
to our customers and will also enable the distribution of our brochures and
information to expectant and nursing mothers through the 1,000 healthcare and
selfcare associates who currently comprise the program.
We also plan to find Fortune 1000 company sponsors for our website such
as car, camcorder, and diaper manufacturers, as well as banking facilities. We
believe that we will be able to attract these companies as sponsors because many
of these companies are currently sponsors for websites that sell competing
products or websites that sell products targeted to our market. As we develop
our target market of new mothers/babies, we will develop an array of sponsors
who will pay for the privilege of reaching the same targeted consumer market.
To assist in financing our business strategy, we executed a tentative
agreement with Pinnacle Asset Management, Inc. ("Pinnacle") on January 31, 2000,
to hire Pinnacle as our exclusive financial advisor concerning any potential
mergers, asset or stock purchases or sales, formation of strategic relationships
or other future financial transactions. However, the terms of compensation to
Pinnacle are still in negotiation.
COMPETITION
We believe that the relationship that we have with LAMI and our
grassroots 1,000 Points of Light Associates Program consisting of healthcare and
selfcare professional associates (which we anticipate to expand into 10,000
Points of Light) puts us in an advantageous position compared with other
existing e-commerce competitors that sell maternal and baby products since we
can sell certain Lamaze brand name products and also may distribute our
rosebaby.com/Lamaze product brochure to participants in Lamaze classroom
training. We believe that Lamaze International and LAMI have not entered into
any similar arrangements with any of our competitors. We have one-on-one
relationships with our targeted customers during the prenatal period through the
Lamaze classroom programs and also have the ability to target new mothers and
infants through distribution of the rosebaby.com/Lamaze product brochure. Our
proposed website product line consists of products from preconception to
postpartum and addresses the needs of infants from the age of one day old to
three years old. We offer products that will be upscale, high quality products
geared toward an increasingly sophisticated, technically-oriented domestic and
international market and will soon develop a popular price-point line of quality
products.
While we believe we have a competitive edge because of the Lamaze
Agreement and our 1,000 Points of Light Associates Program, we do face
considerably better financed competitors which are traditional store-based
retailers or on-line retailers with existing websites such as Ibaby.com,
Babycenter.com and Babystyle.com. We expect competition to intensify in the
future because current and new competitors can enter our market with little
difficulty and can launch new websites at a relatively low cost. If more
companies enter the e-commerce markets, we could experience price reductions,
reduced gross margins and loss of market share, any of which could seriously
harm our net sales and results of operations. In addition, the children's
products industries, including toys, video games, software, video, books, music
and baby-oriented products, are intensely competitive.
Almost all of our competitors and potential competitors presently have
considerably greater financial and other resources, experience and market
penetration than we do. Many traditional store-based and on-line
8
<PAGE>
competitors have longer operating histories, larger customer or user bases,
greater brand recognition and significantly greater financial, marketing and
other resources than we do. Many of these competitors can devote substantially
more resources to website development than we can. In addition, larger,
well-established and well-financed entities may join with on-line competitors or
suppliers of children's products, including toys, video games, books, software,
video, music and baby-oriented products as the use of the Internet and other
on-line services increases. We also compete with several well-established
distributors of prenatal/post-partum products such as Gerber, Evenflo and Avent
in our B-to-B Specialty and Mass Merchant business operations.
RAW MATERIALS
We primarily use fabric as the only raw material in our operations. We
purchase fabric from a variety of suppliers based upon best price estimates. We
believe that we would be able to find various alternative suppliers to either
replace or supplement the suppliers that we currently utilize.
SEASONALITY
Many Internet e-commerce companies experience a disproportionate amount
of sales during the fourth calendar quarter and we anticipate that this will
continue in the future. If the market makes the transition from an emerging to a
more developed market, we may experience some seasonal and cyclical patterns,
including lower advertising revenues in the first and third quarters. Seasonal
and cyclical patterns in Internet advertising may also affect our revenues.
Additionally, we may be affected by website traffic fluctuations during the
summer and year-end vacation and holiday periods and increased sales from
consumer goods during the fourth quarter as a result of the holiday seasons.
Due to our limited operating history, it is difficult to predict the
seasonal pattern of our sales and the impact of such seasonality on our business
and financial results. In the future, our seasonal sales patterns may become
more pronounced, may strain our personnel and warehousing and order shipment
activities and may cause a shortfall in net sales as compared to expenses in a
given period.
EMPLOYEES
We currently employ fifteen individuals full-time and use one part-time
consultant. We anticipate hiring additional employees as we grow.
GOVERNMENT REGULATION, SAFETY, ENVIRONMENTAL COMPLIANCE
There are not currently many direct federal, state or local regulations
other than regulations applicable to conducting business in general or directly
applicable to operating an e-commerce business. It is possible that in the
future a number of laws and regulations may be adopted with respect to the
Internet covering issues such as user privacy, freedom of expression, pricing,
content and quality of products and services, taxation, advertising,
intellectual property rights and information security. Several states have
proposed legislation to limit the uses of personal user information gathered
on-line or require on-line services to establish privacy policies. The Federal
Trade Commission has also initiated action against at least one on-line service
regarding the manner in which personal information is collected from users and
provided to third parties. However, the expansion of the e-commerce market could
lead to adoption of more stringent consumer protection laws and could reduce
consumers' use of the web and demand for our products and services.
The FTC has legislated several laws related to consumer protection
which apply to our business and operations and regulate children's video
marketing and mail/telephone order shipping practices. Our failure to
9
<PAGE>
comply with the FTC rules and regulations or other governmental authorities
could result in action being taken against us and could be detrimental to our
operations.
We also may be affected by the application of existing laws governing
issues such as property ownership, copyrights, encryption and other intellectual
property issues, taxation, libel, obscenity and export or import matters,
although these laws are not as clear about their governance over the Internet.
Changes in laws intended to address such issues could create uncertainty in
e-commerce and our particular market. This uncertainty could reduce demand for
our products or services or increase the cost of doing business because of
higher litigation costs or increased service delivery costs. Liability from
lawsuits may cause our reputation and our business to suffer. In the past,
plaintiffs have brought these types of claims and sometimes successfully
litigated them against on-line services.
ITEM 2. DESCRIPTION OF PROPERTY
We have recently relocated our primary offices to 1535 Northgate
Boulevard, Sarasota, Florida 34234. We currently lease approximately 9,300
square feet of space at our location in Florida under a written lease agreement
at a base rental cost of $3,875 per month, as increased by the Consumer Price
Index on an annual basis. With taxes and maintenance expenses included, we pay
$4,955 a month in rent for our space. The lease expires on August 31, 2002.
We use this space for our administrative and distribution operations.
We believe that this space is adequately insured and is currently suitable as
our main administrative office and distribution center. We do not have offices
at any additional locations, and we have currently no proposed plans for the
renovation, improvement or development of the facilities currently being leased
now. However, servers and other hardware and software that we use for our
website operations are located at the offices of Sun Remarketing in Smithfield,
Utah, as well as other site locations in the Sarasota, Florida area.
ITEM 3. LEGAL PROCEEDINGS
We are not a party in any material legal matters, and we know of no
other proceeding threatened against us. We know of no governmental action
against us. None of our directors, officers, affiliates or beneficial owners of
five percent or more of any class of the Company's voting securities are
threatening to or are bringing a lawsuit against us.
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
There have been no items that we have submitted to our shareholders for
a vote.
10
<PAGE>
PART II
ITEM 5. MARKET FOR THE COMPANY'S COMMON EQUITY AND RELATED STOCKHOLDER MATTERS
MARKET INFORMATION
There is no public trading market for our common stock. Our common
stock does not trade and has never traded, on or through any exchange,
established quotation or listing system or market-maker. Although we would like
to find a market-maker to make quotes for the common stock on the National
Association of Securities Dealers, Inc. OTC Bulletin Board in the future, we can
make no assurance to you that we will be able to find a market-maker, nor can we
assure you that, if we succeed in obtaining a listing for our securities on the
OTC Bulletin Board or on some other exchange, a trading market for the common
stock will develop. The outstanding options or warrants are exercisable into
1,115,000 shares common stock. We have sold common stock in several private
offerings with the share price for such sales ranging from $.50 to $1.50. Our
current offering is at $1.50 per share.
At March 22, 2000, approximately 285 shareholders of record owned our
common stock.
PRIVATE SALES
In March 1996, we (operating as Vascular International of Nevada, Inc.)
initially issued 14,000,000 shares of common stock to the shareholders of the
then public parent corporation, Vascular International, Inc., as a 1:1 share
dividend, which effectively transferred the assets and shareholders of the
parent corporation to The Rose Group Delaware. Such issuance was made pursuant
to Section 4(2) of the Securities Act.
In December 1997, we issued 600,000 shares (after giving effect to a
reserve stock split) of common stock to our then present management and
affiliates for the purpose of securing interim capitalization of $14,500 and
reorganizational services. Such issuance was made pursuant to Section 4(2) of
the Securities Act.
On December 15, 1997, we authorized a 50:1 reverse stock split and
issued 20,000 post-reverse split shares of common stock to a director, 20,000
post-reverse split shares of our common stock to our Utah-based legal counsel
and 25,000 post-reverse split shares of common stock to our President. Such
issuance was made pursuant to Section 4(2) of the Securities Act.
On December 15, 1997, we entered into an Exchange of Stock Agreement
and Plan of Reorganization with Rose Group Delaware and issued, effective March
13, 1997, 4,500,000 shares of common stock to the sole shareholder of Rose Group
Delaware, in exchange for all of his shares in Rose Group Delaware. Such
issuance was made pursuant to Section 4(2) of the Securities Act.
Pursuant to a letter termination agreement, dated November 17, 1998, we
agreed to issue a total of 75,000 shares of common stock and to repay an
outstanding advance to a consulting company as compensation for services
rendered and in full release of all obligations under a Financial Consulting
Agreement dated January 22, 1998, as amended by letter agreement dated May 8,
1998. Subsequent to March 31, 1999, the 75,000 shares were issued pursuant to
Section 4(2) of the Securities Act.
On March 24, 1999, we sold and issued 200,000 shares of common stock to
a sophisticated corporate investor, at a purchase price of fifty cents ($.50)
per share or an aggregate price of $100,000. Upon issuance, we agreed not to
issue shares of common stock in excess of ten percent of the amount outstanding
on March 24, 1999 for a price less than fifty cents per share without the prior
approval of the investor. In connection with the
11
<PAGE>
issuance of these shares, Mr. Jaffe, a greater than five percent beneficial
owner of common stock, agreed to repurchase 100,000 of these shares at a price
of seventy-five cents ($.75) per share. We have agreed to indemnify Mr. Jaffe
for any and all costs and expenses which he may incur in connection with any
litigation resulting from the sale of common stock to such investor. See
"Certain Relationships and Related Transactions." Such issuance was made
pursuant to Rule 504 of Regulation D under the Securities Act.
On March 24, 1999, in consideration for a $100,000 bridge loan, we sold
and issued options to purchase 100,000 shares of common stock at a purchase
price of fifty cents ($.50) per share to Andrew Freundlich. Such options are
exercisable at any time until June 30, 2001, and are subject to adjustments for
stock splits, exchange of shares or otherwise. The $100,000 bridge loan was
evidenced by a promissory note and was paid in its entirety by December 31,
1999. Robert H. Jaffe received a $5,000 finder's fee in connection with the
bridge loan and related issuance and Mr. Freundlich received a $15,000 placement
fee. The issuance was made pursuant to Section 4(2) of the Securities Act.
On March 26, 1999, we issued 50,000 shares of common stock to Robert H.
Jaffe in payment for services rendered to us in connection with the (i)
negotiation of reductions in various outstanding obligations, and (ii)
introduction to companies that could aid in the preparation of an e-commerce
website. Such issuance was made pursuant to Section 4(2) of the Securities Act.
On March 26, 1999, we issued 50,000 shares of common stock to each of
Steven H. Rose, Dr. Francine H. Nichols, Spencer Halper and Mark C. Nicholas for
services rendered to us during the first quarter of 1999. Such issuance was made
pursuant to Section 4(2) of the Securities Act.
On March 30, 1999, we sold and issued 100,000 shares of common stock to
a sophisticated individual investor, at a purchase price of fifty cents ($.50)
per share or an aggregate price of $50,000. In connection with the issuance of
these shares, Mr. Jaffe agreed to repurchase 50,000 of these shares at a price
of seventy-five cents ($.75) per share. We have agreed to indemnify Mr. Jaffe
for any and all costs and expenses which he incurs in connection with any
litigation resulting from the sale of common stock to such investor. See
"Certain Relationships and Related Transactions." Such issuance was made
pursuant to Rule 504 of Regulation D under the Securities Act.
On April 8, 1999, we sold and issued 100,000 shares of common stock to
a sophisticated individual investor, at a purchase price of fifty cents ($.50)
per share or an aggregate price of $50,000. Such issuance was made pursuant to
Rule 504 of Regulation D under the Securities Act.
During the period beginning July 1, 1999 and ending September 15, 1999,
we raised capital by offering shares of common stock by selling to private
investors in compliance with Regulation D of the Securities and Exchange
Commission. We used some of the proceeds of the sales to finance the costs and
development of our website to pay the costs of printing an initial 500,000
rosebaby.com/Lamaze product brochures and to build exhibits and send
representatives of the Company to conventions, including the Lactation
Consultants in Scotsdale, Arizona, the Cologne Germany Fair and the Lamaze
International Convention in Toronto, Canada. We will use the remaining proceeds
of the sales to print an additional 500,000 rosebaby.com/Lamaze product
brochures to purchase and/or secure inventory, to pay for the initial print
advertisements in LAMAZE PARENTS MAGAZINE and LAMAZE BABY MAGAZINE, as well as
other consumer publications, and to build exhibits and send representatives of
the Company to future conferences/tradeshows.
On July 1, 1999, we sold and issued 40,000 shares of common stock to a
charitable investment fund, at a purchase price of fifty cents ($.50) per share
or an aggregate price of $20,000. Such issuance was made
12
<PAGE>
pursuant to Rule 505 of Regulation D under the Securities Act. Robert H. Jaffe
received a five percent finder's fee in connection with this issuance.
On July 9, 1999, we sold and issued 50,000 shares of common stock to a
sophisticated individual investor, at a purchase price of fifty cents ($.50) per
share or an aggregate price of $25,000. Such issuance was made pursuant to Rule
505 of Regulation D under the Securities Act.
On July 12, 1999, we sold and issued 50,000 shares of common stock to a
sophisticated individual investor, at a purchase price of fifty cents ($.50) per
share or an aggregate price of $25,000. Such issuance was made pursuant to Rule
505 of Regulation D under the Securities Act. Robert H. Jaffe received a five
percent finder's fee in connection with this issuance.
On July 14, 1999, in recognition of each of his or her efforts, we
issued options to purchase 550,000 shares of common stock at $1.00 per share to
Sheldon R. Rose, options to purchase 150,000 shares at $1.00 per share to Robert
H. Jaffe and options to purchase 50,000 shares at $1.00 per share to each of
Steven H. Rose, Dr. Francine H. Nichols, Lori M. Majeski, Mark C. Nicholas and
Jared Rose. The amount of shares underlying each of the above-noted options
shall double if we achieve gross sales in excess of $100,000,000 if each
individual is still a key employee, officer, director, consultant or legal
counsel. Such issuance was made pursuant to Section 4(2) of the Securities Act.
On July 21, 1999, we issued 50,000 shares of common stock to Sun
Remarketing as part of Sun Remarketing's agreement to provide services in
connection with the development of our website. Such issuance was made pursuant
to Section 4(2) of the Securities Act.
On July 21, 1999, we sold and issued 150,000 shares of common stock to
four sophisticated individual investors, at a purchase price of fifty cents
($.50) per share or an aggregate price of $75,000. Such issuances were made
pursuant to Rule 505 of Regulation D under the Securities Act. Robert H. Jaffe
received a five percent finder's fee in connection with those issuances.
On July 27, 1999, we sold and issued 10,000 shares of common stock to a
sophisticated individual investor, at a purchase price of fifty cents ($.50) per
share or an aggregate price of $5,000. Such issuance was made pursuant to Rule
505 of Regulation D under the Securities Act. Robert H. Jaffe received a five
percent finder's fee in connection with this issuance.
On August 3, 1999, we sold and issued 50,000 shares of common stock to
two sophisticated individual investors, at a purchase price of fifty cents
($.50) per share or an aggregate price of $25,000. Such issuances were made
pursuant to Rule 505 of Regulation D under the Securities Act. Robert H. Jaffe
received a five percent finder's fee in connection with those issuances.
On August 5, 1999, we sold and issued 200,000 shares of common stock to
three sophisticated investors, at a purchase price of fifty cents ($.50) per
share or an aggregate price of $100,000. Such issuances were made pursuant to
Rule 505 of Regulation D under the Securities Act. Robert H. Jaffe received a
five percent finder's fee in connection with those issuances.
On August 13, 1999, we sold and issued 30,000 shares of common stock to
three sophisticated individual investors, at a purchase price of fifty cents
($.50) per share or an aggregate price of $15,000. Such issuances were made
pursuant to Rule 505 of Regulation D under the Securities Act. Robert H. Jaffe
received a five percent finder's fee in connection with those issuances.
13
<PAGE>
On August 19, 1999, we issued and sold 200,000 shares of common stock
to an existing shareholder of the Company at a purchase price of fifty cents
($.50) per share or an aggregate price of $100,000. The issuance of these
200,000 shares was completed in compliance with Section 4(2) of the Securities
Act.
On August 23, 1999, we sold and issued 105,000 shares of common stock
to five sophisticated individual investors, at a purchase price of fifty cents
($.50) per share or an aggregate price of $52,500. Such issuances were made
pursuant to Rule 505 of Regulation D under the Securities Act. Robert H. Jaffe
received a five percent finder's fee in connection with those issuances.
On August 31, 1999, we sold and issued 52,000 shares of common stock to
four sophisticated individual investors, at a purchase price of fifty cents
($.50) per share or an aggregate price of $26,000. Such issuances were made
pursuant to Rule 505 of Regulation D under the Securities Act. Robert H. Jaffe
received a five percent finder's fee in connection with those issuances.
On September 13, 1999, we sold and issued 30,000 shares of common stock
to two sophisticated individual investors, at a purchase price of fifty cents
($.50) per share or an aggregate price of $15,000. Such issuances were made
pursuant to Rule 505 of Regulation D under the Securities Act. Robert H. Jaffe
received a five percent finder's fee in connection with those issuances.
During October 1999, we sold and issued 640,000 shares of common stock
to thirteen sophisticated individual investors at a purchase price of fifty
cents ($.50) per share, or an aggregate price of $320,000. Such issuances were
made pursuant to Rule 505 of Regulation D under the Securities Act. Robert H.
Jaffe received a five percent finder's fee in connection with those issuances.
In November 1999, convertible promissory notes in the amount of
$300,000 were issued to five lenders. The notes bear interest at a rate of six
percent per annum, are due on June 30, 2000 and are convertible into 300,000
shares of common stock.
We are currently conducting a private offering of up to 1,250,000 units
to accredited and sophisticated investors. Each unit consists of one share of
common stock at a per share price of $1.50 and one warrant to purchase one share
of common stock, exercisable at $1.50 per share. The warrants are exercisable
for three years from the date the offering is closed, or at our discretion, if
the publicly traded price per share exceeds $5.00 for a period of ten
consecutive business days. We are offering a minimum of 750,000 units on an "all
or none" basis, and the remaining 500,000 units on a "best efforts" basis. The
gross proceeds from this offering will go to expansion of our B-to-C E-Commerce
and B-to-B Specialty and Mass Merchant Divisions. At December 31, 1999, we had
sold 72,700 shares to accredited and sophisticated investors at a purchase price
of $1.50 per share, for an aggregate of $109,050. Such subscriptions were made
under Rule 505 of Regulation D.
All of the above purchasers acquired the securities for investment and
there was no general advertising or general solicitations in connection with the
offer and sale of the securities. We believe that each purchaser was given
access to financial and other information with respect to the Company and in
connection with these sales.
Other than the transactions listed above, we have carried out no other
unregistered sales of securities since our incorporation.
14
<PAGE>
DIVIDEND POLICY
We have not paid any dividends to shareholders who own common stock.
The Board of Directors will decide in the future if we will pay dividends, if
any, depending upon our earnings, capital requirements and financial condition
and other important factors. The Board will probably decide to keep all of our
profits, if any, to use in our business operations. Under Nevada corporate law,
dividends may be paid out of surplus or, in case there is no surplus, out of net
profits for the fiscal year that the dividend is declared in and/or the
proceeding fiscal year.
ITEM 6. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION
The following discussion and analysis should be read along with our
Financial Statements and related notes thereto included elsewhere in this Annual
Report.
RESULTS OF OPERATIONS
TWELVE MONTHS ENDED DECEMBER 31, 1999 AND 1998
SALES
Sales for the year ended December 31, 1999 were $389,110, as
compared to $195,364 for the year ended December 31, 1998, an increase of
$193,746, or 99%. This increase is primarily the result of the distribution of
Lamaze brand-name products to Target Stores and Babies-R-Us.
COST OF SALES
Cost of sales for the year ended December 31, 1999 were $201,636,
or 52% of sales, as compared to $116,301 or 60% of sales for the same period in
1998. The increase in cost of sales is due to the increase of sales. The
decrease in cost of sales as a percentage of sales is due to the change in
product mix.
As a result of the foregoing, we realized an increase in gross
profit in 1999 as compared to 1998, with a gross profit of $187,474 or 48% of
sales in the year ended December 31, 1999, as compared to $79,063 or 40% of
sales achieved during the same period in 1998.
GENERAL AND ADMINISTRATIVE EXPENSES
General and administrative expenses amounted to $1,367,887 or 352%
of sales for the year ended December 31, 1999, as compared to $327,025 or 167%
of sales for the same period in 1998. The increase of $1,040,862 is primarily
due to an increase of salaries and other compensation for services rendered.
CATALOGUE AND WEBSITE EXPENSES
Catalogue and website expenses amounted to $244,027 for the year
ended December 31, 1999, as compared to $0 for the same period in 1998. The
increase is the result of the Company transitioning the capitalized costs of
developing printed catalogues into a website based marketing tool during 1999.
15
<PAGE>
INTEREST EXPENSE
Interest expense for the year ended December 31, 1999 was $33,192,
as compared to interest expense of $24,800 in the year ended December 31, 1998.
The primary reason for the $8,392 increase in interest expense was due to
obtaining more debt.
LOSS BEFORE INCOME TAXES
The preceding factors combined to show an increase in the net loss
totaling $1,179,777 in the year ended December 31, 1999, as compared to the year
ended December 31, 1998. There was a net loss of $1,458,524 in 1999, as compared
to a net loss of $278,747 for the comparable period in 1998.
LIQUIDITY AND CAPITAL RESOURCES
We had a working capital deficit of $219,343 at December 31, 1999,
which represented an increase in the deficit of $27,626 from the working capital
deficit of $191,717 at December 31, 1998. The increase in the deficit is mainly
due to an increase in short-term notes payable.
From inception, our operations have been funded by operating
revenue, capital contributions, loans from corporate officers, and a bank line
of credit. In addition, through December, 1999, we consummated private
placements of 2,007,000 shares of our common stock. Our operating activities
used cash of $1,044,319 and $229,714 for the years ended December 31, 1999 and
1998, respectively. The principal use of cash in 1999 and 1998 was to finance
operating expenses.
Our investing activities used cash of $37,900 and $6,821 for the
fiscal years ended December 31, 1999 and 1998, respectively. The principal use
of cash in these periods was for the acquisition of various types of equipment.
Our financing activities provided cash of $1,085,004 and $188,899
for the years ended December 31, 1999 and 1998, respectively. Loans from Sheldon
R. Rose, loans from investors, utilization of our line of credit and the net
proceeds from the Regulation D offerings were the principal sources of cash
during these periods. See "Recent Sales of Unregistered Securities."
In January 1999, Rose Group Delaware, d/b/a in the State of
Florida as "Fresh Babies, Inc.," obtained a line of credit facility of $30,000
from AmSouth Bank of Florida. Such line bears interest at a rate of 2% over
prime (10.15% at December 31, 1999), is due on demand, and is secured by a
pledge of all inventory and is personally guaranteed by a majority stockholder.
In March 1999, a bridge loan in the amount of $100,000 was
obtained from one lender. The loan bore interest at a rate of six percent per
annum and was paid in full by December 31, 1999. In connection with the bridge
loan, we issued options to purchase 100,000 shares of common stock to the
lender. See "Recent Sales of Unregistered Securities."
In November 1999, convertible debentures in the amount of $300,000
were issued to five lenders. The debentures bear interest at a rate of six
percent per annum, are due on June 30, 2000 and are convertible into 300,000
shares of common stock.
As of December 1999, we have completed a series of private
placements totaling 2,007,000 shares of common stock at a purchase price of $.50
per share. We have received gross proceeds of $1,004,568 from these
16
<PAGE>
private placements and such proceeds have been or will be utilized to finance
the costs and development of our website, print rosebaby.com/Lamaze product
brochures, purchase inventory and to finance other working capital expenses.
In October 1999, our website, rosebaby.com, became operational and we
arranged to print 500,000 rosebaby.com/Lamaze product brochures. We anticipate
that sales from our website will initially be slow, but will increase
substantially after the existence of the website is made known to attendees of
Lamaze classes through distribution of the rosebaby.com/Lamaze product
brochures.
We have entered into a Factoring Agreement with Bay View Funding
whereby Bay View Funding purchases certain of our receivables for an advance
price equal to 85% of the face value of such receivables and receives a
factoring and financing fee for such services.
During the next twelve months, our cash requirements will include,
among other things, our lease payments on our office space, salaries payable,
payments pursuant to contractual arrangements, legal and accounting costs
associated with Securities and Exchange Commission filing requirements, as well
as miscellaneous overhead. We anticipate that our existing cash resources and
cash generated from operations will not be sufficient to fund our day-to-day
operations during fiscal year 2000 and that we will require additional funding
in the range of $1,000,000 to $1,500,000 during such year.
We are currently conducting a private offering of up to 1,250,000 units
to accredited and sophisticated investors. Each unit consists of one share of
common stock at a per share price of $1.50 and one warrant to purchase one share
of common stock, exercisable at $1.50 per share. The warrants are exercisable
for three years from the date the offering is closed, or at our discretion, if
the publicly traded price per share exceeds $5.00 for a period of ten
consecutive business days. We are offering a minimum of 750,000 units on an "all
or none" basis, and the remaining 500,000 units on a "best efforts" basis. The
gross proceeds from this offering will go to expansion of our B-to-C E-Commerce
and B-to-B Specialty and Mass Merchant Divisions. At December 31, 1999, we had
sold 72,700 shares to accredited and sophisticated investors at a purchase price
of $1.50 per share, for an aggregate of $109,050. Such subscriptions were made
under Rule 505 of Regulation D.
We believe that we will be able to achieve a positive cash flow from
operations when monthly sales from our website reach approximately $1,000,000.
When monthly sales reach such level, we anticipate that our existing cash
resources and cash generated from operations will be sufficient to fund our
ongoing operations and provide for the cash requirements for our day-to-day
operations, as well as satisfying legal and accounting costs associated with
filing the requisite reports under the Securities and Exchange Act of 1934.
PLAN OF OPERATIONS FOR THE COMPANY
You may find a description of our plan of operations in the section of
this report called, "Business Strategy" under Item 1 above.
SAFE HARBOR STATEMENT
The Private Securities Litigation Reform Act of 1995 provides a new
"safe harbor" for certain forward-looking statements. Statements contained in
this report that are not historical facts are forward-looking statements that
involve risks and uncertainties that could cause our actual results to differ
materially from those stated in the forward-looking statements. Factors that
could cause our actual results to differ materially include, general economic
conditions, changes in laws and government regulations, fluctuations in demand
for our products and
17
<PAGE>
services, our ability to consummate strategic alliances, technology development
problems, and our ability to successfully finance future plant and equipment
plans, as well as our current ongoing operations.
ITEM 7. FINANCIAL STATEMENTS
Our financial statements are located at the end of the report following
Item 13.
<TABLE>
<CAPTION>
<S> <C>
Report of Independent Certified Public Accountant......................................................... F-1
Consolidated Financial Statements:
Consolidated Balance Sheet at December 31, 1999........................................................... F-2
Consolidated Statements of Operations for the years ended December 31, 1999, 1998
and the period March 13, 1997 (date of inception) to December 31, 1997................................ F-3
Consolidated Statements of Cash Flows for the years ended December 31, 1999, 1998
and the period March 13, 1997 (date of inception) to December 31, 1997................................F-4 - F-5
Consolidated Statements of Changes in Stockholders' Deficit for the period
March 13, 1997 (date of inception) through December 31, 1999..........................................F-6 - F-7
Notes to Consolidated Financial Statements................................................................F-8 - F-21
</TABLE>
ITEM 8. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
FINANCIAL DISCLOSURE
We have made no changes in or had disagreements with our independent
accountants during our two most recent fiscal years or any later interim period.
PART III
ITEM 9. DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS,
COMPLIANCE WITH SECTION 16(a) OF THE EXCHANGE ACT
The directors, executive officers and significant employees of the
Company are as follows:
NAME AGE POSITION WITH COMPANY
Sheldon R. Rose 61 Chief Executive Officer, President
and Chairman of the Board
Dr. Francine H. Nichols 63 Director
Spencer Halper 65 Director
Steven H. Rose 54 Director
Lori M. Majeski 43 Vice President - Marketing
Mark C. Nicholas 31 Vice President - Operations
MR. SHELDON R. ROSE. Mr. Rose has had extensive business experience
with American Machine & Foundry Co. (1960-1964) where he completed his services
as the Manager of Long Range Planning for the Aerospace General Engineering
Division. Mr. Rose also worked for Cutler Hammer as a Sales Engineer from
18
<PAGE>
1964-1968. From 1969-1972, he was Vice President of Marketing for Computer
Solutions, Inc., where he provided computer hardware and software related
services to accountants, distributors and small to medium size business
organizations. He was Corporate Acquisition Marketing Manager for Teleprocessing
Industries, a division of Western Union from 1972-1975. In 1975-1982, he was
President of Ambassador Corporation, a prenatal and postpartum product services
company. From 1982 through approximately March, 1997, he was affiliated with
Diplomat Corporation as its founder, Chairman and Chief Executive Officer.
DR. FRANCINE H. NICHOLS. Dr. Nichols is currently an outside director
and consultant to our business. Dr. Nichols obtained her Ph.D. degree in nursing
from the University of Texas in 1984, with an emphasis on parent/child research
and child health issues. Dr. Nichols presently serves as President of MCH
Consultants specializing in maternal and child health care. She is also the
author of numerous books, articles and film productions related to "How To's" on
infant care with particular emphasis on infant products. She was a Visiting
Associate Professor in the School of Nursing at the Catholic University of
America in Washington, D.C. from 1991 through 1993. Dr. Nichols has also had
extensive affiliations with The University of Kansas School of Medicine and
Wichita State University where she has been a Clinical Assistant Professor of
Pediatrics (School of Medicine) and Associate Professor (School for Nursing) in
charge of The Maternal Child Nursing Graduate Program. She was also President
and board member of ASPO/LAMAZE from 1984 through 1991, the National LAMAZE
Childbirth Organization headquartered in Washington, D.C.
MR. SPENCER HALPER. Mr. Halper has had extensive business experience in
developing businesses into leading national brands in the specialty catalog
industry. He started Consumer Distributing Catalog Showrooms in 1973 through
1976 as director of advertising and marketing. Mr. Halper worked for Hanover
Direct (1976-1995) and held several positions, including Executive Vice
President of the Specialty Catalog Division.
MR. STEVEN H. ROSE. Mr. Rose has been Chairman and President of Rose
Research for approximately the past eight years and has been actively working in
the marketing research field for more than twenty-five years. Mr. Rose is an
Executive Member of the American Marketing Association and has made numerous
speeches to various client and trade organizations. In addition, he has been
quoted in a number of marketing books and publications pertaining to research
and new methodological applications in the 1990's. Prior to forming Rose
Research, Mr. Rose was associated with Daniel Yankelovich for nearly twenty
years. Mr. Rose has been at the forefront of the marketing research industry
from the early days of Yankelovich, Skelly and White, to becoming a founding
partner of the Daniel Yankelovich Group/DYG.
MS. LORI M. MAJESKI. Ms. Majeski has worked in the marketing and
product development field for over twenty years, and has spent the past four
years operating her own consulting company. Her consulting activities focus upon
retail, marketing, merchandising and product development services for children's
educational toys, juvenile accessories and infant and children's apparel. Prior
to founding her own consulting company, Ms. Majeski worked for Mamiye Brothers,
Inc. (1994-1995) and Donnkenny, Inc. (1993-1994) where she was directly
responsible for the design, product development, production and merchandising of
high-end children's wear apparel lines for the Walt Disney Company and
affiliated entities thereof.
MR. MARK C. NICHOLAS. Mr. Nicholas began his career in 1989 with
Diplomat Corporation, a NASDAQ publicly traded corporation. He served as
Director of Operations and directed all of the warehouse and distribution
functions for over 150 products for eight years. Part of his responsibilities
included distribution of products to mass merchants and a National LAMAZE Premie
Catalogue. Mr. Nicholas has an Associates Degree in Business Management from
Rockland Community College, Suffern, New York and is currently completing his
Bachelor of Arts degree at Eckert College.
19
<PAGE>
Each of the above individuals, with the exception of Ms. Majeski, has
held his or her position since March 13, 1997. Ms. Majeski became the Vice
President-Marketing in July 6, 1999.
Sheldon R. Rose and Steven H. Rose are brothers and Mark C. Nicholas is
the son-in-law of Sheldon R. Rose. There are no other family relationships
between directors and/or executive officers.
COMPLIANCE WITH SECTION 16(a) OF THE SECURITIES EXCHANGE ACT OF 1934
Officers and directors, and persons who beneficially own, directly or
indirectly, more than ten percent (10%) of the registered class of public equity
securities must file reports of ownership and changes in ownership on Forms 3, 4
and 5 with the Securities and Exchange Commission ("SEC") and the National
Association of Securities Dealers because of requirements of Section 16(a) of
the Securities Exchange Act of 1934 and give us a copy of what form was filed.
The officers, directors and 10% beneficial owners timely filed the
Initial Statement of Beneficial Ownership on Form 3 and timely filed the Annual
Statement of Beneficial Ownership on Form 5 for the fiscal year end disclosing
each individual's ownership of common stock and options.
ITEM 10. EXECUTIVE COMPENSATION
The following table contains information about the compensation paid
during the three years ended on December 31, 1999 to (i) the Chief Executive
Officer of the Company and (ii) all other executive officers of the Company, or
any of its subsidiaries, who held an executive position on December 31, 1999 and
received total salary and bonus in excess of $100,000 during fiscal year ended
December 31, 1999 (collectively, "Named Executive Officers").
SUMMARY COMPENSATION TABLE
<TABLE>
<CAPTION>
ANNUAL COMPENSATION LONG TERM COMPENSATION AWARDS
-------------------- ------------------------------------------
NAME OF INDIVIDUAL RESTRICTED STOCK SECURITIES
AND PRINCIPAL POSITION YEAR SALARY BONUS AWARDS UNDERLYING OPTIONS
- - ---------------------- ---- ------ ----- ------ ------------------
<S> <C> <C> <C> <C> <C>
Sheldon R. Rose, Chief 1999 $ 69,000 - - -
Executive Officer, 1998 120,000 - - -
President and Chairman of 1997 14,381 - - -
the Board
</TABLE>
20
<PAGE>
The following table contains information regarding options granted in
the fiscal year ended December 31, 1999 to the directors and executive officers
named in the Summary Compensation Table above. For the fiscal year ended
December 31, 1999, we granted options to acquire up to an aggregate of 950,000
shares to employees and directors.
<TABLE>
<CAPTION>
OPTION GRANTS IN LAST FISCAL YEAR
(INDIVIDUAL GRANTS)
NUMBER OF SECURITIES % OF TOTAL OPTIONS
UNDERLYING OPTIONS GRANTED TO EMPLOYEES EXERCISE PRICE EXPIRATION
NAME GRANTED (#) IN FISCAL YEAR ($/SH) DATE
---- ----------- -------------- ------ ----
<S> <C> <C> <C> <C> <C>
Sheldon R. Rose 550,000 58% 1.00 7/14/2002
</TABLE>
The following table sets forth information with respect to the number
and value of outstanding options held by executive officers named in the Summary
Compensation Table above at December 31, 1999.
FISCAL YEAR-END OPTION VALUES
<TABLE>
<CAPTION>
NUMBER OF SECURITIES UNDERLYING VALUE OF UNEXERCISED IN-THE-MONEY
UNEXERCISED OPTIONS AT YEAR END (#) OPTIONS AT YEAR END ($)
NAME EXERCISABLE UNEXERCISABLE EXERCISABLE UNEXERCISABLE
---- ----------- ------------- ----------- -------------
<S> <C> <C> <C> <C>
Sheldon R. Rose 550,000 -0- * -0-
</TABLE>
- - ----------
* The value of unexercised in-the-money options is based upon the difference
between the price of our common stock on December 31, 1999 and the exercise
price of the options. We do not have a market for our common stock that the
option is exercisable into, therefore there is no market price to compare
with the exercise price to determine if the options are in-the-money or
out-of-the-money.
STOCK INCENTIVE PLAN
We have reserved 2,050,000 shares of common stock for issuance if
options are exercised, and we will give those options to future management
professionals.
COMPENSATION OF DIRECTORS
We compensate outside directors $500 per day to attend meetings of the
Board of Directors. We have also granted certain directors options for their
services.
21
<PAGE>
EMPLOYMENT AGREEMENTS
Sheldon Rose has an employment agreement effective July 1, 1999. Mr.
Rose acts as the Chairman, Chief Executive Officer and President of the Company
and receives an annual salary of $120,000 under his employment agreement. When
we achieve gross sales in an amount equal to $50,000,000, Mr. Rose's base salary
shall be increased to $180,000 per annum. Mr. Rose will receive another increase
to $240,000 per annum when we achieve gross sales equal to $100,000,000. Mr.
Rose shall receive an additional $30,000 per annum for every $50,000,000
increase in gross sales. The employment agreement will remain in effect until
July 1, 2004, when it will be automatically extended for successive one year
periods unless one party notifies the other within sixty days written notice
that they want to terminate the agreement.
If there is a change of control, our successor entity will have the
right to terminate the Employment Agreement, but it must make payment to Mr.
Rose in an amount equal to two times his annual salary at the time the agreement
is terminated.
We have made consulting arrangements with Dr. Francine H. Nichols who
is a director. We pay consulting fees of approximately $1,442 per week to Dr.
Nichols.
There are no provisions in our Articles of Incorporation or By-laws
that would delay or prevent a change of control of the company.
22
<PAGE>
ITEM 11. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The following table contains information about the beneficial ownership
of the equity securities owned by each beneficial owner of more than five
percent of our common stock, by each director and Named Executive Officer at
December 31, 1999 (as defined in applicable SEC regulations), and by all
directors and executive officers as a group. For purposes of this table, a
beneficial owner is one who, directly or indirectly, has or shares with others
(a) the power to vote or direct the voting of the common stock or (b) investment
power with respect to the common stock which includes the power to dispose or
direct the disposition of the common stock.
<TABLE>
<CAPTION>
NAME AND ADDRESS OF NUMBER OF SHARES OF COMMON PERCENTAGE OWNERSHIP OF
BENEFICIAL OWNER STOCK BENEFICIALLY OWNED(1) COMMON STOCK OUTSTANDING(1)(2)
---------------- --------------------------- ------------------------------
<S> <C> <C>
Sheldon R. Rose 3,802,000(3) 42.76%
8990 Wembley Court
Sarasota, FL 34238
Robert H. Jaffe 959,150(4) 11.29%
8 Mountain Avenue
Springfield, NJ 07081
Dr. Francine H. Nichols 150,000(5) 1,79%
2138 California Street, N.W.
Suite 203
Washington, D.C. 20008
Steven H. Rose 150,000(5) 1.79%
483 Alexander Palm Road
Boca Raton, FL 33432
Spencer Halper 110,000 1.32%
15 Ardsleigh Place
Jamesburg, NJ 08831
All Directors and Executive Officers 4,212,000(6) 46.84%(6)
as a Group (4 Persons)
</TABLE>
- - ----------
(1) Includes any Options issued and outstanding that could be exercised
within sixty days from March 1, 2000.
(2) Based upon 8,342,231 shares of common stock outstanding at March 22,
2000.
(3) Includes currently exercisable options to purchase 550,000 shares of
common stock. The Option Agreements which govern the terms of the noted
options provide that the amount of shares which the holder may purchase
upon exercise shall double if we reach $100,000,000 in gross sales if
the holder is still a key employee, officer, director, consultant or
legal counsel at the company.
(4) Includes currently exercisable options to purchase 150,000 shares of
common stock and 34,250 shares held by Portfolio Promotions
International, Ltd., of which Mr. Jaffe is the sole shareholder. The
Option Agreements which govern the terms of the noted options provide
that the amount of shares which the holder may purchase upon exercise
shall double if we reach $100,000,000 in gross sales if the holder is
still a key employee, officer, director, consultant or legal counsel at
the company.
23
<PAGE>
(5) Includes currently exercisable options to purchase 50,000 shares of
common stock. The Option Agreements which govern the terms of the noted
options provide that the amount of shares which the holder may purchase
upon exercise shall double if we reach $100,000,000 in gross sales if
the holder is still a key employee, officer, director, consultant or
legal counsel at the company.
(6) Includes an aggregate of 650,000 shares of common stock issuable upon
exercise of outstanding options and warrants. The Option Agreements
which govern the terms of the noted options provide that the amount of
shares which the holder may purchase upon exercise shall double if we
reach $100,000,000 in gross sales if the holder is still a key
employee, officer, director, consultant or legal counsel at the
company.
ITEM 12. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
LOANS. We entered into a loan with Sheldon R. Rose, the Chairman, Chief
Executive Officer and President of the Company, for $350,000 and signed a
promissory note to repay certain advances made by Mr. Rose for the payment of
various business expenses. The promissory note bears interest at a rate of six
percent each year and is payable each year, and the principal amount is due and
payable in full on December 31, 2001.
INDEMNIFICATION AGREEMENTS. Robert H. Jaffe, a greater than five
percent beneficial owner of the Company's common stock, has made an agreement to
repurchase all or a portion of 150,000 shares of common stock owned by two
investors, at a price of seventy-five cents ($.75) per share at any time during
the period commencing March 25, 2000 and ending September 30, 2000. We have
indemnified Mr. Jaffe for any and all costs and expenses which he may have to
pay if any litigation results.
ITEM 13. EXHIBITS AND REPORTS ON FORM 8-K
(a) The following Exhibits are filed as part of this Report:
2. Plan of Acquisition, Reorganization, Arrangement,
Liquidation or Succession
2.1 Exchange of Stock Agreement and Plan of
Reorganization by and between the Company (as
Vascular International of Nevada, Inc.) and Rose
Group Delaware, dated December 15, 1997
(incorporated by reference to our Form 10-SB filed
with the Securities and Exchange Commission on
December 7, 1999).
3. Articles of Incorporation and Bylaws
3.1 Articles of Incorporation of Vascular International
of Nevada, Inc., filed February 13, 1996
(incorporated by reference to our Form 10-SB filed
with the Securities and Exchange Commission on
December 7, 1999).
3.2 Certificate of Amendment of Articles of
Incorporation of Vascular International of Nevada,
Inc., changing name of company to The Rose Group
Corporation of Nevada, filed March 13, 1997
(incorporated by reference to our Form 10-SB filed
with the Securities and Exchange Commission on
December 7, 1999).
3.3 Bylaws of The Rose Group Corporation of Nevada (then
named Vascular International of Nevada, Inc.)
(incorporated by reference to our Form 10-SB filed
with the Securities and Exchange Commission on
December 7, 1999).
24
<PAGE>
10. Material Contracts
10.1 Lease Agreement for 2073 Porter Lake Drive, Sarasota
Florida for period September 1, 1998 to August 31,
1999 (incorporated by reference to our Form 10-SB
filed with the Securities and Exchange Commission on
December 7, 1999).
10.2 Employment Agreement by and between the Company and
Sheldon R. Rose effective as of July 14, 1999
(incorporated by reference to our Form 10-SB filed
with the Securities and Exchange Commission on
December 7, 1999).
10.3 Licensing Agreement for "Privacy Shawl" by and
between the Company and Pretty/Private, dated
January 9, 1998 (incorporated by reference to our
Form 10-SB filed with the Securities and Exchange
Commission on December 7, 1999).
10.4 Exclusive Sales Agreement by and between the Company
and LAMAZE for AMI, Inc. effective as of February
24, 1999 (incorporated by reference to our Form
10-SB filed with the Securities and Exchange
Commission on December 7, 1999).
10.5 Factoring Agreement and amendments thereto, by and
between the Company and Bay View Funding dated
August 5, 1997 and March 22, 1999, respectively
(incorporated by reference to our Form 10-SB filed
with the Securities and Exchange Commission on
December 7, 1999).
10.6 Line of Credit Agreement, by and between The Rose
Group Company of Delaware d/b/a in Florida as Fresh
Babies, Inc. and AmSouth Bank of Florida, dated
January 25, 1999 (incorporated by reference to our
Form 10-SB filed with the Securities and Exchange
Commission on December 7, 1999).
10.7 Lease Agreement for 1535 Northgate Boulevard,
Sarasota, Florida for the period September 1, 1999
to August 31, 2002 (incorporated by reference to our
Form 10-SB filed with the Securities and Exchange
Commission on December 7, 1999).
10.8 Agreement, dated as of October 15, 1999, by and
between Sun Remarketing, Inc. and the Company
(incorporated by reference to our Form 10-SB filed
with the Securities and Exchange Commission on
December 7, 1999).
10.9 Advertising and Promotion Agreement by and between
Yahoo! Inc. and The Rose Group Corporation of Nevada
dated February 15, 2000 (to be filed by amendment).
10.10 Sales Agreement by and between LAMAZE from AMI, Inc.
and The Rose Group of Corporation of Nevada dated
March 15, 2000
11. Statement Re Computation of Per Share Earnings
See Notes to Financial Statements
21. Subsidiaries of Small Business Issuer
25
<PAGE>
21.1 List of Subsidiaries
27. Financial Data Schedule
(b) Reports on Form 8-K during the quarter ended December 31, 1999:
None
26
<PAGE>
SIGNATURES
In accordance with Section 13 or 15(d) of the Securities Exchange Act
of 1934, the registrant caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
THE ROSE GROUP CORPORATION OF NEVADA
Date: March 30, 2000 By: /s/ Sheldon R. Rose
------------------------------------
Sheldon R. Rose
Chief Executive Officer, President,
Chairman of the Board and Principal
Financial Officer
In accordance with the Securities Exchange Act of 1934, this report has
been signed by the following persons and in the capacities and on the dates
indicated.
<TABLE>
<CAPTION>
SIGNATURE TITLE DATE
--------- ----- ----
<S> <C> <C>
/s/ Sheldon R. Rose
- - --------------------------------- Chairman of the Board March 30, 2000
Sheldon R. Rose
/s/ Francine H. Nichols
- - --------------------------------- Director March 30, 2000
Dr. Francine H. Nichols
/s/ Spencer Halper
- - --------------------------------- Director March 30, 2000
Spencer Halper
/s/ Sheldon R. Rose
- - --------------------------------- Director March 30, 2000
Steven H. Rose
</TABLE>
27
<PAGE>
CONSOLIDATED FINANCIAL STATEMENTS
THE ROSE GROUP CORPORATION
OF NEVADA AND SUBSIDIARIES
(A DEVELOPMENT STAGE ENTERPRISE)
YEARS ENDED DECEMBER 31, 1999 AND 1998 AND PERIOD
MARCH 13, 1997 (DATE OF INCEPTION) TO DECEMBER 31, 1999
INDEPENDENT AUDITORS' REPORT
<PAGE>
The Rose Group Corporation
of Nevada and Subsidiaries
(A Development Stage Enterprise)
Consolidated Financial Statements
Years Ended December 31, 1999 and 1998 and
Period March 13, 1997 (Date of Inception) to December 31, 1999
CONTENTS
Independent Auditors' Report on Consolidated Financial Statements...........F-1
Consolidated Financial Statements:
Consolidated Balance Sheet..............................................F-2
Consolidated Statements of Operations...................................F-3
Consolidated Statements of Changes in Stockholders' Deficit.......F-4 - F-5
Consolidated Statements of Cash Flows ............................F-6 - F-7
Notes to Consolidated Financial Statements........................F-8 - F-21
<PAGE>
INDEPENDENT AUDITORS' REPORT
Board of Directors
The Rose Group Corporation of Nevada and Subsidiaries
(A Development Stage Enterprise)
Sarasota, Florida
We have audited the accompanying consolidated balance sheet of The Rose Group
Corporation of Nevada and Subsidiaries (a development stage enterprise) as of
December 31, 1999 and the related consolidated statements of operations, changes
in stockholders' deficit, and cash flows for the years ended December 31, 1999
and 1998 and the period March 13, 1997 (date of inception) to December 31, 1999.
These consolidated financial statements are the responsibility of the management
of The Rose Group Corporation of Nevada and Subsidiaries. Our responsibility is
to express an opinion on these consolidated financial statements based on our
audits.
We conducted our audits in accordance with generally accepted auditing
standards. These standards require that we plan and perform the audits to obtain
reasonable assurance about whether the consolidated financial statements are
free of material misstatement. An audit includes examining, on a test basis,
evidence supporting the amounts and disclosures in the consolidated financial
statements. An audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall
consolidated financial statement presentation. We believe that our audits
provide a reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred to above present
fairly, in all material respects, the financial position of The Rose Group
Corporation of Nevada and Subsidiaries as of December 31, 1999 and the results
of its operations and its cash flows for the years ended December 31, 1999 and
1998 and the period March 13, 1997 (date of inception) to December 31, 1999 in
conformity with generally accepted accounting principles.
/s/ Pender Newkirk & Company
Certified Public Accountants
Tampa, Florida
March 21, 2000
F-1
<PAGE>
The Rose Group Corporation
of Nevada and Subsidiaries
(A Development Stage Enterprise)
Consolidated Balance Sheet
December 31, 1999
<TABLE>
<CAPTION>
ASSETS
Current assets:
<S> <C>
Cash $ 3,793
Cash held in trust accounts 193,954
Accounts receivable, factor 7,801
Advances to stockholder 81,608
Inventory 142,099
Prepaid expenses 9,000
--------------
Total current assets 438,255
Property and equipment, net of accumulated depreciation 73,402
Other assets 10,127
--------------
$ 521,784
==============
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities:
Accounts payable, trade, including related party of $71,177 $ 267,640
Notes payable and current portion of long-term debt 340,105
Current portion of capital lease obligation 10,126
Accrued expenses 39,727
--------------
Total current liabilities 657,598
--------------
Long-term liabilities:
Note payable, stockholder 350,000
Capital lease obligation 24,718
Common stock payable 74,050
--------------
Total long-term liabilities 448,768
--------------
Stockholders' deficit
Preferred stock; $.001 par value; 2,000,000 shares
authorized; no shares issued and outstanding
Common stock; $.001 par value; 50,000,000 shares
authorized; 7,845,670 shares issued and outstanding 7,846
Additional paid-in capital 1,180,596
Accumulated deficit during development stage (1,773,024)
--------------
Total stockholders' deficit (584,582)
--------------
$ 521,784
==============
</TABLE>
READ INDEPENDENT AUDITORS' REPORT. THE ACCOMPANYING NOTES
ARE AN INTEGRAL PART OF THE CONSOLIDATED FINANCIAL STATEMENTS. F-2
<PAGE>
The Rose Group Corporation
of Nevada and Subsidiaries
(A Development Stage Enterprise)
Consolidated Statements of Operations
<TABLE>
<CAPTION>
March 13,
1997 (Date of
YEAR ENDED DECEMBER 31, Inception) to
-------------------------------- December 31,
1999 1998 1999
----------------------------------------------------
<S> <C> <C> <C>
Sales $ 389,110 $ 195,364 $ 1,051,673
Cost of sales 201,636 116,301 572,278
----------------------------------------------------
Gross profit 187,474 79,063 479,395
----------------------------------------------------
Operating expenses:
General and administrative 1,367,887 327,025 1,917,476
Depreciation and amortization 18,644 5,985 27,040
Interest expense 33,192 24,800 70,343
Catalog and website expenses 244,037 244,037
----------------------------------------------------
Total operating expenses 1,663,760 357,810 2,258,896
----------------------------------------------------
Net loss from operations (1,476,286) (278,747) (1,779,501)
Other income 17,762 17,762
----------------------------------------------------
Net loss $ (1,458,524) $ (278,747) $ (1,761,739)
=====================================================
Loss per share $(.23) $(.06) $(.44)
=====================================================
</TABLE>
READ INDEPENDENT AUDITORS' REPORT. THE ACCOMPANYING NOTES
ARE AN INTEGRAL PART OF THE CONSOLIDATED FINANCIAL STATEMENTS. F-3
<PAGE>
The Rose Group Corporation
of Nevada and Subsidiaries
(A Development Stage Enterprise)
Consolidated Statements of Changes in Stockholders' Deficit
Years Ended December 31, 1999 and 1998 and Period
March 13, 1997 (Date of Inception) to December 31, 1999
<TABLE>
<CAPTION>
Accumulated
Common Stock Additional Deficit During
------------ Paid-In Development Stock
Shares Amount Capital Stage Subscription Total
----------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C>
Stock issued for cash
(March 1997) 100 $1,000 $ 1,000
Net loss for the period $ (24,468) (24,468)
----------------------------------------------------------------------------------------
Balance, December 31, 1997 100 1,000 (24,468) (23,468)
Acquisition of company
(March 1998) 5,463,670 5,464 $ 412,093 (404,414) $ (14,500) (1,357)
Recapitalization of company
(March 1998) (100) (1,000) (412,093) 393,129 14,500 (5,464)
Net loss for the year (278,747) (278,747)
----------------------------------------------------------------------------------------
Balance, December 31, 1998 5,463,670 5,464 (314,500) (309,036)
Sale of stock for cash, net of
offering cost of $51,750
(March 1999) 300,000 300 97,950 98,250
Stock options issued in
connection with loan
(March 1999) 5,400 5,400
Stock issued for services
rendered (March 1999) 250,000 250 124,750 125,000
Contribution of services
(March 1999) 28,000 28,000
Contribution of services
(March 1999) 75,000 75,000
Contribution of offering costs
(March 1999) 30,000 30,000
</TABLE>
READ INDEPENDENT AUDITORS' REPORT. THE ACCOMPANYING NOTES
ARE AN INTEGRAL PART OF THE CONSOLIDATED FINANCIAL STATEMENTS. F-4
<PAGE>
The Rose Group Corporation
of Nevada and Subsidiaries
(A Development Stage Enterprise)
Consolidated Statements of Changes in Stockholders' Deficit
Years Ended December 31, 1999 and 1998 and Period
March 13, 1997 (Date of Inception) to December 31, 1999
<TABLE>
<CAPTION>
Accumulated
Common Stock Additional Deficit During
----------------- Paid-In Development Stock
Shares Amount Capital Stage Subscription Total
----------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C>
Sale of stock for cash, net of
offering costs of $17,350
(June 1999) 100,000 100 32,650 32,750
Stock issued in connection
with accounts payable
(June 1999) 75,000 75 37,425 37,500
Contribution of offering costs
(June 1999) 10,000 10,000
Sale of stock for cash, net of
offering costs of $58,840
(September 1999) 967,000 967 424,660 (12,500) 413,127
Stock issued for services
(September 1999) 50,000 50 24,950 25,000
Collection of stock
subscription
(December 1999) 12,500 12,500
Sale of stock for cash, net
of offering costs of
$29,550 (December 1999) 640,000 640 289,811 290,451
Net loss for the year ended
December 31, 1999 (1,458,524) (1,458,524)
----------------------------------------------------------------------------------------
Balance, December 31, 1999 7,845,670 $7,846 $1,180,596 $(1,773,024) $ 0 $ (584,582)
========================================================================================
</TABLE>
READ INDEPENDENT AUDITORS' REPORT. THE ACCOMPANYING NOTES
ARE AN INTEGRAL PART OF THE CONSOLIDATED FINANCIAL STATEMENTS. F-5
<PAGE>
The Rose Group Corporation
of Nevada and Subsidiaries
(A Development Stage Enterprise)
Consolidated Statements of Cash Flows
<TABLE>
<CAPTION>
March 13,
1997 (Date of
YEAR ENDED DECEMBER 31, Inception) to
------------------------------- December 31,
1999 1998 1999
--------------------------------------------------
OPERATING ACTIVITIES
<S> <C> <C> <C>
Net loss $ (1,458,524) $ (278,747) $ (1,761,739)
--------------------------------------------------
Adjustments to reconcile net loss to net
cash used by operating activities:
Depreciation 18,644 5,985 26,506
Amortization of prepaid loan costs 5,400 5,400
Stock issued for services 150,000 150,000
Contribution of services 103,000 103,000
(Increase) decrease in:
Accounts receivable, factor 18,680 (7,801)
Inventory (77,358) (143) (142,099)
Prepaid assets (9,000) (9,000)
Catalogue costs 199,972 (124,422)
Other assets (7,190) (10,127)
Increase in:
Accounts payable and other accrued
expenses 30,737 111,433 296,004
Stock payable 37,500 37,500
-------------------------------------------------
Total adjustments 414,205 49,033 449,383
-------------------------------------------------
Net cash used by operating activities (1,044,319) (229,714) (1,312,356)
--------------------------------------------------
INVESTING ACTIVITIES
Acquisition of property and equipment (32,063) (59,227)
Payment under capital lease obligations (5,837) (5,837)
Acquisition of Vascular International of
Nevada, Inc., net (6,821) (6,821)
--------------------------------------------------
Net cash used by investing activities (37,900) (6,821) (71,885)
--------------------------------------------------
FINANCING ACTIVITIES
Net borrowings on line of credit 29,766 29,766
Proceeds from notes payable 255,096 255,096
Payments on notes payable (64,661) (64,661)
Advances to stockholder (81,608) (81,608)
Proceeds from note payable, stockholder 322,138 350,000
Payments on note payable, stockholder (116,761)
Payments on offering costs (58,157) (16,478) (106,127)
Proceeds from issuance of common stock 1,004,568 1,005,568
-------------------------------------------------
Net cash provided by financing activities 1,085,004 188,899 1,388,034
-------------------------------------------------
</TABLE>
READ INDEPENDENT AUDITORS' REPORT. THE ACCOMPANYING NOTES
ARE AN INTEGRAL PART OF THE CONSOLIDATED FINANCIAL STATEMENTS. F-6
<PAGE>
The Rose Group Corporation
of Nevada and Subsidiaries
(A Development Stage Enterprise)
Consolidated Statements of Cash Flows
<TABLE>
<CAPTION>
March 13,
1997 (Date of
YEAR ENDED DECEMBER 31, Inception) to
------------------------------- December 31,
1999 1998 1999
-------------------------------------------------
<S> <C> <C> <C>
NET INCREASE (DECREASE) IN CASH 2,785 (47,636) 3,793
CASH AT BEGINNING OF YEAR 1,008 48,644
--------------------------------------------------
CASH AT END OF YEAR $ 3,793 $ 1,008 $ 3,793
==================================================
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
AND NONCASH INVESTING AND FINANCING ACTIVITIES
Cash paid during the year for interest $ 33,192 $ 0 $ 45,543
=================================================
</TABLE>
Included in accounts payable at December 31, 1999 and 1998 is approximately
$11,000 and $31,000, respectively, related to offering costs.
During the year ended December 31, 1999, the Company entered into a capital
lease for equipment with a fair market value of $40,681.
During 1999, the Company issued stock valued at $37,500 in connection with
accounts payable.
Included in cash held in escrow is approximately $120,000 of proceeds from
notes payable and $74,000 of monies received for stock to be issued.
During 1999, the Company's President sold stock to investors for less than
fair market value. The Company recorded the difference between the selling
price and the fair market value of the stock of $40,000 as contribution to
capital and a corresponding offering cost.
READ INDEPENDENT AUDITORS' REPORT. THE ACCOMPANYING NOTES
ARE AN INTEGRAL PART OF THE CONSOLIDATED FINANCIAL STATEMENTS. F-7
<PAGE>
The Rose Group Corporation
of Nevada and Subsidiaries
(A Development Stage Enterprise)
Notes to Consolidated Financial Statements
Years Ended December 31, 1999 and 1998 and Period
March 13, 1997 (Date of Inception) to December 31, 1999
1. BACKGROUND AND OTHER INFORMATION
On March 10, 1998, The Rose Group Corporation of Nevada (the "Parent"), formerly
known as Vascular International of Nevada, Inc., acquired all of the outstanding
common stock of The Rose Group Corporation, a Delaware corporation. The
consolidated entities will be referred to as the "Company." For accounting
purposes, the acquisition has been treated as a recapitalization of The Rose
Group Corporation with The Rose Group Corporation as the acquiror (reverse
acquisition). The historical financial statements prior to March 10, 1998 are
those of The Rose Group Corporation. Pro forma information giving effect to the
acquisition as if the acquisition took place on March 13, 1997 (date of
inception of The Rose Group Corporation) is as follows:
<TABLE>
<CAPTION>
March 13,
1997 (Date of
YEAR ENDED DECEMBER 31, Inception) to
--------------------------------- December 31,
1999 1998 1999
------------------------------------------------------
<S> <C> <C> <C>
Net sales $ 389,110 $ 195,364 $ 1,051,673
======================================================
Net loss $ (1,458,524) $ (278,747) $ (1,768,501)
======================================================
Basic loss per common stock $(.23) $(.06) $(.44)
======================================================
</TABLE>
The Parent was incorporated in the state of Nevada on February 6, 1996 and was a
public shell corporation at the time of acquisition. The Rose Group Corporation
was incorporated in the state of Delaware on March 13, 1997. Rosebaby.com of
Utah, Inc., a wholly owned subsidiary of the Parent, was incorporated on April
29, 1999 in the state of Utah.
Management of the Company plans to continue to develop the Company as a prenatal
and postpartum selfcare and healthcare manufacturer, wholesaler, mass marketer
to retail outlets, and direct seller to consumers through its Internet
E-commerce facilities of certain products and related consulting services that
are marketed under the nationally known trademark and brand name "LAMAZE." The
Company also intends to market other nationally known brands of products for
newborns and toddlers through its ROSEBABY.COM website and supplemental
catalogues.
The headquarters of the Company is located in Sarasota, Florida.
The Company is considered a development stage enterprise devoting substantially
all of its efforts to establishing customer and vendor relationships, to
establishing complete product lines, and to raising capital through private
placement sales.
READ INDEPENDENT AUDITORS' REPORT. F-8
<PAGE>
The Rose Group Corporation
of Nevada and Subsidiaries
(A Development Stage Enterprise)
Notes to Consolidated Financial Statements
Years Ended December 31, 1999 and 1998 and Period
March 13, 1997 (Date of Inception) to December 31, 1999
1. BACKGROUND AND OTHER INFORMATION (CONTINUED)
The Company had sales to significant customers of $351,543 in 1999, $77,648 in
1998, and $742,564 for the period March 13, 1997 (date of inception) to December
31, 1999, respectively, which made up ninety percent, thirty-nine percent, and
seventy-one percent of the Company's total sales for those respective periods.
The accompanying consolidated financial statements have been prepared in
conformity with generally accepted accounting principles which contemplate
continuation of the Company as a going concern. The Company incurred operating
losses of $1,761,739 since inception and has negative working capital of
$219,343 as of December 31, 1999. Total liabilities exceed total assets by
$584,582 as of December 31, 1999. As indicated in Note 15, subsequent to
year-end, the Company raised approximately $1,833,000 by means of a private
placement offering of its common stock at $1.50 per share. Management believes
that actions presently taken to raise additional capital by means of this
private placement sale of its common stock and a subsequent secondary public
offering will provide the opportunity for the Company to continue as a going
concern.
2. SIGNIFICANT ACCOUNTING POLICIES
The significant accounting policies followed are:
The accompanying consolidated financial statements include the accounts
of the Parent and its wholly owned subsidiaries, The Rose Group
Corporation (a Delaware corporation) and Rosebaby.com of Utah, Inc. (a
Utah corporation), hereinafter referred to as the "Subsidiaries." All
significant intercompany transactions have been eliminated in the
consolidation.
The preparation of consolidated financial statements in conformity with
generally accepted accounting principles requires management to make
estimates and assumptions that affect the reported amounts of assets and
liabilities and disclosure of contingent assets and liabilities at the
date of the consolidated financial statements and the reported amounts
of revenues and expenses during the reporting period. Actual results
could differ from those estimates.
READ INDEPENDENT AUDITORS' REPORT. F-9
<PAGE>
The Rose Group Corporation
of Nevada and Subsidiaries
(A Development Stage Enterprise)
Notes to Consolidated Financial Statements
Years Ended December 31, 1999 and 1998 and Period
March 13, 1997 (Date of Inception) to December 31, 1999
2. SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
Cash held in trust accounts represents monies held by the Company's
attorney, which was raised from the proceeds of notes payable and sales
of common stock.
Inventory is stated at the lower of cost (first-in, first-out) or
market.
Property and equipment are recorded at cost. Depreciation is calculated
by the accelerated method over the estimated useful lives of the assets,
ranging generally from 5 to 15 years. Additions to and major
improvements of property and equipment are capitalized. Maintenance and
repair expenditures are charged to expense as incurred. As property and
equipment are sold or retired, the applicable cost and accumulated
depreciation are eliminated from the accounts and any gain or loss is
recorded.
When the Company has long-lived assets that have a possible impairment
indicator, the Company estimates the future cash flows from the
operation of these assets. If the estimated cash flows recoup the
recorded value of the assets, they remain on the books at that value. If
the net recorded value cannot be recovered, the assets are written down
to their fair market value if lower than the recorded value.
Revenue is recognized once products are shipped. The Company sells to
its customers based on its standard credit policies and regularly
reviews accounts receivable providing for any bad debts. At December 31,
1999, management believes that all accounts receivable are fully
collectible and no allowance for bad debt is required.
In connection with the Company's private placements, offering costs are
deferred and offset against the proceeds of the offering or expensed if
the offering is unsuccessful.
Basic loss per share (EPS) is computed by dividing loss available to
common stockholders by the weighted average number of shares of common
stock outstanding for the period. Diluted EPS reflect the potential
dilution from the exercise or conversion of securities into common
stock. Diluted EPS are not presented because they are anti-dilutive.
READ INDEPENDENT AUDITORS' REPORT. F-10
<PAGE>
The Rose Group Corporation
of Nevada and Subsidiaries
(A Development Stage Enterprise)
Notes to Consolidated Financial Statements
Years Ended December 31, 1999 and 1998 and Period
March 13, 1997 (Date of Inception) to December 31, 1999
2. SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
Advertising costs (except for costs associated with direct-response
advertising) are charged to operations when incurred. The costs of
direct-response advertising are capitalized and amortized over the
period during which future benefits are expected to be received.
Advertising expense for the years ended December 31, 1999 and 1998 and
the period March 13, 1997 (date of inception) to December 31, 1999 was
$73,799, $4,914, and $85,001, respectively.
Deferred tax assets and liabilities are measured using enacted tax rates
expected to be applied to taxable income in the years in which those
temporary differences are expected to be recovered or settled. The
effect of a change in tax rates on deferred tax assets and liabilities
is recognized as income in the period that included the enactment date.
The Financial Accounting Standards Board issued Statement No. 123,
"Accounting for Stock-Based Compensation" (FASB No. 123), effective for
fiscal years beginning after December 15, 1995. This statement provides
that expense equal to the fair value of all stock-based awards on the
date of the grant be recognized over the vesting period. Alternatively,
this statement allows entities to continue to apply the provisions of
Accounting Principles Board Opinion No. 25, "Accounting for Stock Issued
to Employees" (APB Opinion No. 25), whereby compensation expense is
recorded on the date the options are granted to employees equal to the
excess of the market price of the underlying stock over the exercise
price. The Company has elected to continue to apply the provisions of
APB Opinion No. 25 and provide pro forma disclosure of the provisions of
FASB No. 123.
In accordance with the Securities and Exchange Commission Staff
Accounting Bulletin 1:B, the Company recorded as an expense and as
additional paid-in capital the estimated fair value for services
provided to it by its President and Vice President of Operations that
were not paid with cash.
In accordance with the Securities and Exchange Commission Staff
Accounting Bulletin 5:T, the Company recorded as operating expense and
as additional paid-in capital the fair value of stock transferred by the
President to Directors for services rendered on behalf of the Company.
READ INDEPENDENT AUDITORS' REPORT. F-11
<PAGE>
The Rose Group Corporation
of Nevada and Subsidiaries
(A Development Stage Enterprise)
Notes to Consolidated Financial Statements
Years Ended December 31, 1999 and 1998 and Period
March 13, 1997 (Date of Inception) to December 31, 1999
3. INVENTORY
Inventory at December 31, 1999 consists of:
Finished goods $ 88,245
Raw materials 53,854
-----------
$ 142,099
===========
4. PROPERTY AND EQUIPMENT
Property and equipment at December 31, 1999 consists of:
Office furniture and fixtures $ 20,915
Equipment 74,195
Leasehold improvements and other 4,798
----------
99,908
Less accumulated depreciation 26,506
----------
$ 73,402
==========
The following is a summary of the property included above, which is held under a
capital lease:
Office furniture and fixtures $ 16,797
Equipment 23,884
----------
40,681
Less accumulated depreciation 1,794
----------
$ 38,887
==========
READ INDEPENDENT AUDITORS' REPORT. F-12
<PAGE>
The Rose Group Corporation
of Nevada and Subsidiaries
(A Development Stage Enterprise)
Notes to Consolidated Financial Statements
Years Ended December 31, 1999 and 1998 and Period
March 13, 1997 (Date of Inception) to December 31, 1999
5. OBLIGATIONS UNDER CAPITAL LEASES
The Company has a capitalized rental obligation for the lease of equipment. The
obligation, which matures in 2002, represents the total present value of future
rental payments discounted at the interest rates implicit in the lease.
Future minimum lease payments under this capital lease are:
Year Ending
DECEMBER 31,
------------
2000 $ 20,319
2001 20,319
2002 11,853
-----------
Total minimum lease payments 52,491
Less amount representing interest 17,647
-----------
Present value of net minimum lease payments 34,844
Less current portion 10,126
-----------
$ 24,718
===========
6. NOTES PAYABLE AND LONG-TERM DEBT
Notes payable and long-term debt consist of:
Line of credit payable; maximum borrowing $30,000; due on demand;
interest at 2.0% over prime (10.5% at December
31, 1999); collateralized by inventory and
personally guaranteed by majority stockholder $ 29,766
Convertible debentures; interest at 6.0%; interest only
payments due quarterly; due June 30, 2000;
unsecured; convertible into 300,000 shares of
common stock at $1.00 per share at the option of
the holder; if converted, the Company must
register these shares within 90 days; if this is
not done, the holders are entitled to an
additional 150,000 shares of common stock 300,000
READ INDEPENDENT AUDITORS' REPORT. F-13
<PAGE>
The Rose Group Corporation
of Nevada and Subsidiaries
(A Development Stage Enterprise)
Notes to Consolidated Financial Statements
Years Ended December 31, 1999 and 1998 and Period
March 13, 1997 (Date of Inception) to December 31, 1999
6. NOTES PAYABLE AND LONG-TERM DEBT (CONTINUED)
Note payable; interest at 9.8%; $5,226 payable per month including
interest; due January 25, 2000;
unsecured 10,339
Note payable, majority stockholder; due December 31,
2001; interest at 6.0% per annum; unsecured 350,000
------------
690,105
Less amounts currently due 340,105
------------
$ 350,000
============
The following is a schedule by year of the principal payments required on these
notes payable and long-term debt:
2000 $340,105
========
2001 $350,000
========
7. LEASE COMMITMENTS
The Company rented office space under an operating lease with a remaining lease
term of less than one year that expired August 31, 1999. Monthly rent payments
were $1,043. On August 19, 1999, the Company entered into a lease agreement for
the leasing of new corporate and warehouse space. Monthly base rental lease
payments are $3,875. The lease expires on August 31, 2002. In addition, the
Company leases equipment under operating leases that have an initial or
remaining noncancelable lease term in excess of one year.
The following is a schedule by year of all future minimum rental payments under
these leases:
2000 $85,366
=======
2001 $68,610
=======
2002 $31,000
=======
Total rent expense amounted to $59,665, $20,081, and $93,572 for 1999, 1998, and
the period March 13, 1997 (date of inception) through December 31, 1999,
respectively.
READ INDEPENDENT AUDITORS' REPORT. F-14
<PAGE>
The Rose Group Corporation
of Nevada and Subsidiaries
(A Development Stage Enterprise)
Notes to Consolidated Financial Statements
Years Ended December 31, 1999 and 1998 and Period
March 13, 1997 (Date of Inception) to December 31, 1999
8. ACCOUNTS RECEIVABLE, FACTOR
The Company entered into an agreement to sell its accounts receivable, with
recourse, to Bayview Growth Corporation (Bayview). The agreement calls for the
immediate payment of eighty-five percent of the face value of the accounts
receivable, with the remaining fifteen percent payable upon collection of the
receivable by Bayview. The Company is charged various factoring and financing
fees amounting to one percent for each 10-day period the receivables are not
collected by Bayview. The amount shown on the consolidated balance sheet at
December 31, 1999 represents the unfunded portion of the receivables not yet
collected by Bayview.
In the event of a default, or 90 days from invoice date, the Company must
repurchase the accounts receivable from Bayview. Losses from defaults have not
been significant. At December 31, 1999, the Company is contingently liable in
the amount of $30,642 relating to such receivables sold with recourse.
9. OTHER COMMITMENTS
On February 28, 1999, the Company executed an exclusive agreement with LAMAZE
from AMI, Inc. (LAMI). This agreement allowed the Company to use the "LAMAZE"
trademark on the advertising, packaging, and marketing materials related to
maternity support hose and nursing shawls. The Company is required to pay a fee
of nine percent of the net sales (sales less returns and allowances) of the
authorized products (listed above) with a minimum yearly fee of $45,000 payable
in installments in January and July of every year.
Subsequent to December 31, 1999, the Company and LAMI entered into a new
agreement calling for a fee equal to five percent of net sales of maternity
support hose, nursing shawls, and maternity and nursing apparel, and a minimum
yearly fee of $50,000 payable in two installments on February and August 15th
through December 31, 2001.
On July 1, 1999, the Company entered into an employment agreement with the Chief
Executive Officer (CEO) and President of the Company. Under the terms of the
agreement, the CEO is to receive an annual salary of $120,000, with incremental
increases based on sales. The agreement will remain in effect until July 1,
2004, when it will be automatically extended for successive one-year periods
unless 60 days written notice is given by one party.
The Company pays one of its Directors $75,000 per year for consulting. There is
no formal written agreement and payments began on September 3, 1999.
READ INDEPENDENT AUDITORS' REPORT. F-15
<PAGE>
The Rose Group Corporation
of Nevada and Subsidiaries
(A Development Stage Enterprise)
Notes to Consolidated Financial Statements
Years Ended December 31, 1999 and 1998 and Period
March 13, 1997 (Date of Inception) to December 31, 1999
9. OTHER COMMITMENTS (CONTINUED)
On October 15, 1999, the Company entered into a written agreement with Sun
Remarketing, Inc. (Sun) to design an E-Commerce website and to provide server
and Internet services. The Company issued 50,000 shares of stock and must pay
Sun a minimum monthly fee of $5,000. The agreement gives Sun the right to
purchase an additional 50,000 shares of common stock at $.50 per share,
exercisable on January 1, 2000 and expiring on December 31, 2000. The agreement
is cancelable by either party upon a 60-day written notice.
The Company has agreed to indemnify one of its stockholders for all costs and
expenses he may incur in connection with any litigation resulting from the sale
of 150,000 shares of the Company's common stock.
10. INCOME TAXES
From the date of inception to February 28, 1998, the Subsidiaries, with the
consent of the stockholders, elected to be taxed under the Internal Revenue Code
as S corporations. In lieu of being assessed corporate income taxes, the
stockholders of an S corporation are taxed on their proportionate share of the
Company's taxable income or loss. As of the date of the merger with Vascular
International of Nevada, Inc., the Subsidiaries became C corporations and will
be taxed as such.
The Company has a loss carryforward of approximately $1,591,000 as of December
31, 1999 that may be applied against future taxable income. This loss gives rise
to a deferred tax asset at December 31, 1999 of approximately $557,000.
Management has established a valuation allowance equal to the amount of the
deferred tax asset due to the uncertainty of the Company's realization of this
benefit.
Loss carryforward $ 557,000
Less valuation allowance 557,000
-----------
Net deferred tax assets $ 0
===========
The loss carryforward expires on December 31, 2014.
READ INDEPENDENT AUDITORS' REPORT. F-16
<PAGE>
The Rose Group Corporation
of Nevada and Subsidiaries
(A Development Stage Enterprise)
Notes to Consolidated Financial Statements
Years Ended December 31, 1999 and 1998 and Period
March 13, 1997 (Date of Inception) to December 31, 1999
11. STOCK OPTIONS
The Company issues stock options as incentives to employers, directors,
investors, and lenders. The following is a summary of stock option activity
during the fiscal year ended December 31, 1999:
Weighted
Average
Number Exercise
of Shares Price
------------------------
Options granted and outstanding at
January 1, 1999 0 $.00
Options granted during the year 1,115,000 .93
-----------------------
Options granted and outstanding at
December 31, 1999 1,115,000 $.93
=======================
The following table summarizes the status of outstanding options at December 31,
1999:
Weighted Average
Exercise Number Remaining
Price of Shares Contractual Life
-----------------------------------------------------
$1.00 950,000 2.54
$1.00 15,000 1.75
$.50 100,000 1.25
$.50 50,000 1.00
As of December 31, 1999, all of the above options were exercisable and expire
between one to three years after the date granted.
READ INDEPENDENT AUDITORS' REPORT. F-17
<PAGE>
The Rose Group Corporation
of Nevada and Subsidiaries
(A Development Stage Enterprise)
Notes to Consolidated Financial Statements
Years Ended December 31, 1999 and 1998 and Period
March 13, 1997 (Date of Inception) to December 31, 1999
11. STOCK OPTIONS (CONTINUED)
The weighted average fair value of the options at their grant date during 1999
was $.005, which resulted in no material difference from net loss or loss per
share as shown in the accompanying statements of operations. The estimated fair
value of each option granted is calculated using the Black-Scholes
option-pricing model. The following summarizes the weighted average of the
assumptions used in the model:
Risk-free interest rate 4.7% to 5.79%
Expected years until exercised 1 - 3
The Company has reserved 2,050,000 shares of common stock for the exercise of
these and other options.
12. STOCKHOLDERS' EQUITY AND OTHER RELATED PARTY TRANSACTIONS
During 1999, the Company advanced its majority stockholder $81,608 to assist in
paying some credit card debt that he incurred in prior years in connection with
his efforts to raise money to finance the Company. This amount bears no
interest, is unsecured, and is due on demand.
The above amount is not necessarily indicative of the amount that would have
been agreed to by independent third parties.
During July 1999, the Company committed to issue and, subsequently issued,
50,000 shares of common stock in exchange for services rendered by a consulting
firm. The cost of the services has been charged to website costs and capital has
been increased by $25,000, representing the excess of the cost of the services
over the par value of the common stock. In accordance with FASB No. 123, the
fair value of the equity instrument was used. The value assigned of $.50 per
share was determined from the most recent third party sale of common stock.
In December 1997, The Rose Group Corporation of Nevada (f/k/a Vascular
International of Nevada, Inc.) completed a private issuance of its common stock
to present management and affiliated parties in which 600,000 shares
(post-reverse split) were issued for interim capitalization of $14,500 and
reorganizational services rendered.
READ INDEPENDENT AUDITORS' REPORT. F-18
<PAGE>
The Rose Group Corporation
of Nevada and Subsidiaries
(A Development Stage Enterprise)
Notes to Consolidated Financial Statements
Years Ended December 31, 1999 and 1998 and Period
March 13, 1997 (Date of Inception) to December 31, 1999
12. STOCKHOLDERS' EQUITY AND OTHER RELATED PARTY TRANSACTIONS (CONTINUED)
During March 1999, the Company issued 250,000 shares of common stock in exchange
for services rendered by management. The cost of the services has been charged
to operations and capital has been increased by $125,000, representing the
excess of the cost of the services over the par value of the common stock. In
accordance with FASB No. 123, the fair value of the equity instrument was used.
The value assigned of $.50 per share was determined from the most recent third
party sale of common stock.
During March 1999, the Company recorded the fair value of services rendered by
the President and Vice President of Operations from January 1, 1999 through
March 31, 1999 by charging operations $28,000 and additional paid-in capital in
accordance with Staff Accounting Bulletin 1:B.
During March 1999, the President transferred 150,000 shares of his common stock
in the Company to Directors for services rendered on behalf of the Company. The
Company charged $75,000 to operations and additional paid-in capital as a result
of this transaction.
During June 1999, the Company issued 75,000 shares of common stock in exchange
for services rendered by a consulting firm. The cost of the service has been
charged to operations and capital has been increased by $37,500. In accordance
with FASB No. 123, the fair value of the equity instrument was used. The value
assigned of $.50 per share was determined from the most recent third party sale
of common stock.
During 1999, the Company sold 2,007,000 shares of common stock for $847,078, net
of offering costs of $157,490.
The Company's President sold 100,000 shares of common stock to some of the
Company's investors at $.10 per share. The Company recorded the difference
between the selling price and the fair market value of underlying stock of $.50
as a contribution to capital by the President and a corresponding offering cost
in the amount of $40,000.
As of December 31, 1999, the Company recorded $74,050 of common stock payable to
investors who had not been issued their respective shares.
READ INDEPENDENT AUDITORS' REPORT. F-19
<PAGE>
The Rose Group Corporation
of Nevada and Subsidiaries
(A Development Stage Enterprise)
Notes to Consolidated Financial Statements
Years Ended December 31, 1999 and 1998 and Period
March 13, 1997 (Date of Inception) to December 31, 1999
13. LOSS PER SHARE
The following data shows the amounts used in computing loss per share and the
weighted average number of shares of common stock:
<TABLE>
<CAPTION>
March 13,
1997 (Date of
Year Ended December 31, Inception) to
--------------------------------- December 31,
1999 1998 1999
------------------------------------------------------
<S> <C> <C> <C>
Net loss $ (1,458,524) $ (278,747) $ (1,761,739)
=======================================================
Weighted average number of
common shares used in
basic EPS 6,409,284 4,612,985 4,043,194
======================================================
</TABLE>
14. BUSINESS SEGMENT INFORMATION
The Company adopted Statements of Financial Accounting Standards No. 131,
"Disclosure About Segments of an Enterprise and Related Information," in 1999.
For 1999, the Company was primarily involved in two lines of business, Business
to Customer E-Commerce and Business to Business Specialty and Mass Merchant. The
following data shows the segmented information as of December 31, 1999:
<TABLE>
<CAPTION>
Business to
Business to Business
Customer Specialty/Mass
E-Commerce Merchant Corporate Total
---------------------------------------------------------
<S> <C> <C> <C> <C>
Sales $ 5,776 $ 383,334 $ 389,110
Cost of sales 15,800 185,836 201,636
----------------------------------------------------------
Gross (loss) profit (10,024) 197,498 187,474
Expenses 502,743 765,535 $ 395,482 1,663,760
----------------------------------------------------------
Operating loss (512,767) (568,037) (1,476,286)
Other income 900 16,156 706 17,762
----------------------------------------------------------
Net loss $ (511,867) $ (551,881) $(394,776) $ (1,458,524)
==========================================================
Total assets $ 90,251 $ 232,131 $ 199,402 $ 521,784
==========================================================
Total liabilities $ 81,332 $ 576,258 $ 448,776 $ 1,106,366
==========================================================
</TABLE>
READ INDEPENDENT AUDITORS' REPORT. F-20
<PAGE>
The Rose Group Corporation
of Nevada and Subsidiaries
(A Development Stage Enterprise)
Notes to Consolidated Financial Statements
Years Ended December 31, 1999 and 1998 and Period
March 13, 1997 (Date of Inception) to December 31, 1999
15. OTHER SUBSEQUENT EVENTS
On January 31, 2000, the Company entered into a tentative agreement with
Pinnacle Asset Management, Inc. (PAMC) to serve as the Company's exclusive
financial advisor in connection with the Company entering into partnerships,
joint ventures, or similar arrangements, possible mergers or stock sales, sales
or other dispositions of business or assets, and other related matters with
which the Company may require assistance. The agreement is for two years and can
be extended by mutual agreement between both parties. Upon execution of this
agreement, 500,000 warrants to purchase 500,000 shares of common stock at $.50
per share are issuable to PAMC. Based on a successful infusion of not less than
$5,000,000 of equity funding during 2000, PAMC will be entitled to an additional
1,750,000 warrants to purchase 1,750,000 shares of common stock at $.50 per
share.
On February 15, 2000, the Company entered into an agreement with Yahoo!, Inc.
(Yahoo!) for advertising and promotion services on Yahoo!'s website. Under the
terms of the agreement, Yahoo! is to provide Internet users with links to the
Company's website, chat room, video streaming, and e-mail. The Company is to pay
Yahoo! $1,000,000 and issue a warrant to purchase 131,185 shares of the
Company's stock at $.50 per share.
The Company additionally executed a Remote Merchant Integration Program
Agreement ("Merchant Agreement") with Yahoo!. Under the Merchant Agreement, in
exchange for Yahoo! displaying the Company's product information and pages from
the Company's website, the Company will pay Yahoo! two percent of revenue that
the Company receives from sales to customers that purchase products through the
Yahoo! shopping website. The payment is due within fifteen days from the end of
each quarter. The Merchant Agreement is for one year and then on a
month-to-month basis after expiration of the term.
Subsequent to year-end, the Company raised approximately $1,833,000 by means of
a $1,875,000 private placement offering. This offering consists of 1,250,000
units, with each unit valued at $1.50 per unit being comprised of one share of
common stock and one warrant to purchase an additional share of common stock for
$1.50.
READ INDEPENDENT AUDITORS' REPORT. F-21
<PAGE>
Exhibit 10.10
SALES AGREEMENT
This agreement effective as of the 15th day of March, 2000, is by and between
LAMAZE from AMI, Inc., a Corporation organized and existing under the laws of
the State of New York, having a place of business at 275 Central Park West, 14th
Floor, New York, New York 10024 ("LAMI") and THE ROSE GROUP CORPORATION OF
NEVADA, a Corporation organized and existing under the laws of the State of
Nevada, and having a place of business at 1535 Northgate Boulevard, Sarasota,
Florida, 34234-4760 ("ROSE").
W I T N E S S E T H
WHEREAS, LAMI represents that it has the exclusive right and license to use the
federally registered trademark LAMAZE in conjunction with the advertising and
distribution of various maternity and nursingwear products by virtue of an
existing Contribution Agreement between LAMAZE International and LAMI, and
WHEREAS, ROSE represents that it has the expertise and knowledge to manufacture,
supply and distribute, bill, and collect for LAMI various products under private
label including the trademark LAMAZE, and remit and account to LAMI for sale of
said products; and
WHEREAS, ROSE desires to obtain the right to sell certain products as approved
by LAMI,
NOW, THEREFORE, in consideration of the mutual covenants herein contained, and
the sum of one dollar, receipt of which is hereby acknowledged, and other good
and valuable consideration, the parties mutually agree as follows:
1. LAMI warrants and represents that it has the exclusive right and
license to use the federally registered trademark LAMAZE in conjunction
with the manufacture, offering for sale, advertising and sale and
distribution of various maternity and nursingwear products pursuant to
a Contribution Agreement between LAMI and LAMAZE International. LAMI
further warrants that Peter Incorvaia is fully authorized to enter into
this Agreement for and on behalf of LAMI.
2. ROSE warrants and represents that Sheldon R. Rose is fully authorized
to enter into this Agreement for and on behalf of ROSE. ROSE further
warrants and represents that it has the necessary expertise, knowledge
and capability to manufacture, supply and distribute, bill, and collect
for LAMI various products under private label including the trademark
LAMAZE, and remit and account to LAMI for the sale of said products.
Initial S.R.R. Initial P.I.
-------- ---------
S.R.R. P.I.
Page 1 of 5
<PAGE>
3. LAMI herby grants to ROSE and ROSE herby accepts from LAMI, upon the
terms and conditions hereinafter specified, the rights to manufacture,
supply, advertise, offer for sale, promote and sell for LAMI the
products enumerated on EXHIBIT "A" annexed hereto ("Authorized
Products") within the United States of America, its territories and
possessions, for the term set forth herein. Except as indicated herein,
for the term of this Agreement, LAMI will not grant any sales rights to
any third party for the manufacture or sale of any of the Authorized
Products. LAMI retains the right to sell any Approved Product through
its own network with the Agreement of ROSE.
4. ROSE shall control and have full responsibility for the manufacture,
packaging, inventory, pricing, shipment, invoicing and collection of
accounts receivable with respect to the Authorized Products.
5. In consideration for the rights granted to ROSE by LAMI in this
Agreement, ROSE has paid to LAMI a minimum of Twenty-Five Thousand
dollars ($25,000.00) as of March 9th, 2000 and shall pay a minimum of
Twenty-Five Thousand dollars ($25,000.00) on the following dates:
August 15th, 2000, on February 15th, 2001, August 15th, 2001 and on
February 15th, 2002. All of the aforementioned payments shall be
non-refundable advances on the fee due to LAMI upon same year net
annual sales of Authorized Products (the "Advances"). The Advances
shall be credited against a five percent (5%) fee payable on sales of
Authorized Products (Maternity Wear products combined with Maternity
Support Hose, and Nursing Privacy Shawl). As used throughout this
Agreement, the term "net sales" shall mean the gross sales proceeds
from the sale of all Authorized Products less any returns by customers
of ROSE or damaged or defective Authorized Products. As used throughout
this Agreement, the term "annual net sales" shall mean the net sales as
defined above for the time period from January 1 through December 31 of
each year of the term of this Agreement. ROSE shall keep such records
as are necessary for LAMI to ascertain the accuracy of the statements.
ROSE shall provide LAMI with annual audited financial statements of the
Lamaze Maternity Wear business.
6. LAMI acknowledges that it has examined ROSE's Authorized Products and
that the quality standards of the samples thereof shown to LAMI are
acceptable to LAMI. ROSE agrees that the Authorized Products shall meet
or exceed such quality standards and LAMI agrees that Authorized
Products that meet or exceed such quality standards shall be acceptable
to LAMI for purposes of this paragraph. ROSE agrees to furnish complete
product specifications to LAMI to establish minimum quality standard
for all Authorized Products.
Initial S.R.R. Initial P.I.
-------- ---------
S.R.R. P.I.
Page 2 of 5
<PAGE>
7. Use of "LAMAZE" Mark: For any use of the "LAMAZE" mark as allowed under
this Agreement in connection with advertising, packaging or marketing
materials, it must at least once place the "R" letter in a circle by
the "LAMAZE" mark, and then in a prominent location place the following
statement "LAMAZE(R) is a registered trademark of LAMAZE International,
Inc."
8. ROSE agrees to defend, indemnify and hold harmless LAMI, LAMAZE
International, their respective officers, directors and shareholders
from and against any and all claims of any third party alleging that
the Authorized Products are defective or have caused injury.
9. ROSE agrees that, during the term of this agreement, it will maintain
product liability insurance having liability limits customary in the
trade, but in no event less than the amounts required by LAMAZE
International to be carried by LAMI. As of the date of this agreement,
LAMAZE International is requiring liability limits of One Million
dollars ($1,000,000.00). LAMI and LAMAZE International shall be named
as "additional insureds" on the product liability policies held by ROSE
and shall provide LAMI with a copy of the declaration page to such
policy as soon as practical after the execution of this Agreement.
10. The term of this Agreement is until December 31, 2001 and may be
renewed by mutual agreement of the parties upon the terms agreed upon
at the time of renewal.
11. This Agreement may be terminated by either party for a material breach
of the provisions herein, upon written notice to the breaching party,
if the breach is not cured within thirty (30) days of receipt of such
notice.
12. All notices herein shall be sent by certified mail, return receipt
requested, postage prepaid, addressed as follows:
If to ROSE: Mr. Sheldon R. Rose, Chairman, CEO
THE ROSE GROUP CORPORATION OF NEVADA 1535 Northgate
Boulevard Sarasota, Florida 34234-4760
If to LAMI: Mr. Peter Incorvaia, President
LAMAZE from AMI, Inc.
275 Central Park West, 14th Floor
New York, New York 10024
Initial S.R.R. Initial P.I.
-------- ---------
S.R.R. P.I.
Page 3 of 5
<PAGE>
13. ROSE expressly acknowledges the ownership by Lamaze International of
the LAMAZE mark, and the right of Lamaze International to pre-approve
all advertising, packaging and promotional materials with the
Authorized Products containing the LAMAZE mark.
14. LAMI acknowledges the proprietary rights to the tradename THE ROSE
GROUP CORPORATION OF NEVADA in Design, and Agrees that ROSE's tradename
may appear on the Authorized Products, labels attached to the
Authorized Products, and the packages in which the Authorized Products
are sold so long as the LAMAZE tradename remains the dominate name
appearing on the Authorized Products, its labels and packaging. ROSE
may not advertise or promote any other products which it manufactures,
now or in the future, along with an Authorized Product in such a way as
to give the appearance that the unauthorized product is in any way
connected with or endorsed by LAMAZE International or LAMI, or that the
unauthorized product is comparable to the Authorized Product.
15. The parties hereto agree to the jurisdiction of the United States
District Courts for the adjudication of disputes relating to the
interpretation of or performance under this Agreement or the improper
use of the parties trademarks or tradenames. The parties further agree
that the laws of the State of New York shall apply to the
interpretation of this Agreement regardless of any prior conflicts of
law determinations.
16. IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be
duly executed in their respective corporate names by their respective
officers thereunto duly authorized as of the day and year hereinabove
first written.
LAMAZE from AMI, INC.
By: /s/ PETER INCORVAIA Date: March 15, 2000
---------------------------------------
Peter Incorvaia, President
THE ROSE GROUP CORPORATION OF NEVADA
By: /s/ SHELDON R. ROSE Date: March 15, 2000
---------------------------------------
Sheldon R. Rose, Chairman / C.E.O
Page 4 of 5
<PAGE>
EXHIBIT "A"
-----------
TO AGREEMENT BETWEEN
LAMAZE from AMI, INC.
AND
THE ROSE GROUP CORPORATION OF NEVADA
- - -------------------------------------------------------------------------------
ITEM STYLE NUMBER
- - -------------------------------------------------------------------------------
- - -------------------------------------------------------------------------------
Nursing Shawl 60620
Maternity Support Hose 70, 80, 82, 84, 86, 88, 90, 92, 94, 96, 98
and
All Maternity And Nursing Sportswear
- - -------------------------------------------------------------------------------
Initial S.R.R. Initial P.I.
-------- ---------
S.R.R. P.I.
Page 5 of 5
<PAGE>
EXHIBIT 21.1
LIST OF SUBSIDIARIES
1. Rosebaby.com of Utah, Inc. - wholly-owned subsidiary of The
Rose Group Corporation of Nevada
2. Rose Group Delaware - wholly-owned subsidiary of The Rose
Group Corporation of Nevada
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FINANCIAL
STATEMENTS FOR THE 12 MONTHS ENDED DECEMBER 31, 1999 AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FORM 10-KSB FOR ANNUAL PERIOD ENDED DECEMBER 31,
1999.
</LEGEND>
<S> <C>
<PERIOD-TYPE> YEAR
<FISCAL-YEAR-END> DEC-31-1999
<PERIOD-START> JAN-01-1999
<PERIOD-END> DEC-31-1999
<CASH> 3,793
<SECURITIES> 0
<RECEIVABLES> 7,801
<ALLOWANCES> 0
<INVENTORY> 142,099
<CURRENT-ASSETS> 438,255
<PP&E> 99,908
<DEPRECIATION> 26,506
<TOTAL-ASSETS> 521,784
<CURRENT-LIABILITIES> 657,598
<BONDS> 0
0
0
<COMMON> 7,846
<OTHER-SE> (592,428)
<TOTAL-LIABILITY-AND-EQUITY> 521,784
<SALES> 389,110
<TOTAL-REVENUES> 389,110
<CGS> 201,636
<TOTAL-COSTS> 201,636
<OTHER-EXPENSES> 1,630,568
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 33,192
<INCOME-PRETAX> (1,458,524)
<INCOME-TAX> 0
<INCOME-CONTINUING> (1,458,524)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (1,458,524)
<EPS-BASIC> (.23)
<EPS-DILUTED> (.23)
</TABLE>
